Gastro-oesophageal reflux disease

K11_REFLUX

gastroesophageal reflux disease: A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K21 Hospital discharge: ICD-9 — 5301A Cause of death: ICD-10 — K21 Cause of death: ICD-9 — 5301A 2 out of 7 registries used, show all original rules.	39174
4. Check minimum number of events None	39174
5. Include endpoints None	39174
6. Filter based on genotype QC (FinnGen only)	37811

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K20-K31
Name in latin: Morbus refluxualis gastro-oesophageus

NAME	K11_REFLUX
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K21
HD_ICD_9	5301A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K21
COD_ICD_9	5301A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Gastro-oesophageal reflux disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	244622	129853	113501
Only index persons	222545	121042	101503
Unadjusted period prevalence (%)
Whole population	3.45	3.72	3.17
Only index persons	4.19	4.45	3.87
Median age at first event (years)
Whole population	54.59	56.28	52.67
Only index persons	54.66	56.25	52.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	37811	22309	15502
Unadjusted period prevalence (%)	7.58	7.91	7.10
Median age at first event (years)	56.81	55.83	58.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
39174: Matched controls
337872

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

323.3

26307

192648

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

322.8

2979

12101

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

322.4

7697

42781

A11

ICPC

Chest pain NOS

2.2

322.3

3041

12464

R96

ICPC

Asthma

2.1

322.3

3592

15706

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

321.7

3243

13646

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

92.4

321.6

192

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

321.3

2255

8124

A01

ICPC

Pain general/multiple sites

2.1

321.2

3350

14284

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

321.0

17190

115247

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

320.4

21440

150502

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

320.2

3728

16564

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

319.2

2105

7362

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

319.2

5384

27087

M01AB55

ATC

diclofenac, combinations; oral

2.4

318.2

2463

9279

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

317.7

14714

95605

M01AH02

ATC

rofecoxib; oral

1.9

315.7

4604

22110

A07AA02

ATC

nystatin; oral

2.5

314.8

2225

8041

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

311.7

3273

13985

M79.7

ICD-10 Finland

Fibromyalgia

3.0

309.6

1441

4188

H02AB07

ATC

prednisone; oral

1.9

309.6

4966

24577

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

309.0

4355

20670

XJC00

NOMESCO Finland

Oesophageal manometry

54.2

307.7

392

H02AB04

ATC

methylprednisolone; systemic

2.0

307.7

5612

26409

A02BX02

ATC

sucralfate; oral

3.8

307.7

1817

4305

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

6184

31525

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

307.7

5162

21875

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

16698

96673

J01CA04

ATC

amoxicillin; systemic

1.7

307.7

30846

231532

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

21202

143632

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.4

307.7

2989

11102

R01AD08

ATC

fluticasone; nasal

1.8

307.7

11237

61838

R02

ICPC

Shortness of breath/dyspnoea

2.0

307.7

4916

22444

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

78.4

307.7

253

J01MA12

ATC

levofloxacin; systemic

1.9

307.7

6983

34770

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

307.7

7929

35172

R03BA08

ATC

ciclesonide; inhalant

2.2

307.7

3537

14291

A02BC01

ATC

omeprazole; systemic

3.5

307.7

14992

50415

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.4

307.7

9370

28647

K92.1

ICD-10 Finland

Melaena

3.0

307.7

1859

5461

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

307.7

2604

9958

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

46.8

307.7

216

K22.7

ICD-10 Finland

Barrett oesophagus

67.9

307.7

1162

152

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

9596

44409

R03DC03

ATC

montelukast; oral

2.1

307.7

6788

31261

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

307.7

4200

19054

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

307.7

2885

10212

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

307.7

885

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

17421

106971

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

307.7

7051

34819

UJC12

NOMESCO Finland

Flexible oesophagoscopy

9.4

307.7

419

390

D03

ICPC

Heartburn

5.0

307.7

2041

3691

N02BE01

ATC

paracetamol; systemic, rectal

2.5

307.7

35043

261546

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

21.8

307.7

286

114

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

307.7

8215

31540

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

192.5

307.7

332

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.4

307.7

1758

3605

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

307.7

3680

15216

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

307.7

9949

44675

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

307.7

5382

25098

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

307.7

3266

13152

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

307.7

3853

16020

R06AE07

ATC

cetirizine; oral

1.6

307.7

16253

104790

M01AH01

ATC

celecoxib; oral

1.9

307.7

6851

34523

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

94.5

307.7

21130

4136

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

307.7

2525

9311

K29.3

ICD-10 Finland

Chronic superficial gastritis

51.7

307.7

1725

301

C05AA08

ATC

fluocortolone; rectal, topical

1.9

307.7

5143

25324

K29.6

ICD-10 Finland

Other gastritis

23.0

307.7

482

183

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

307.7

13397

84529

S18

ICPC

Laceration/cut

1.6

307.7

16704

108447

A06AC51

ATC

ispaghula, combinations; oral

2.8

307.7

2022

6442

K29.7

ICD-10 Finland

Gastritis, unspecified

13.7

307.7

1578

1035

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

307.7

5141

22529

N06AX11

ATC

mirtazapine; oral

1.8

307.7

13392

74565

A03CA02

ATC

clidinium and psycholeptics; oral

2.8

307.7

2343

7461

A03FA02

ATC

cisapride; oral, rectal

4.4

307.7

4334

9302

R13

ICD-10 Finland

Dysphagia

4.8

307.7

4061

7892

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

62.8

307.7

282

A02BC05

ATC

esomeprazole; systemic

5.7

307.7

25560

83347

UKC02

NOMESCO Finland

Cystoscopy

1.9

307.7

5880

28547

D02

ICPC

Abdominal pain epigastric

3.2

307.7

2731

7832

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

14.0

307.7

8185

6248

R07.0

ICD-10 Finland

Pain in throat

2.4

307.7

2721

10346

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

307.7

4900

22020

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

17601

116675

K22.1

ICD-10 Finland

Ulcer of oesophagus

236.8

307.7

1429

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

138.7

307.7

461

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

307.7

9672

54926

XF402

NOMESCO Finland

ECG with work load test

2.4

307.7

4375

16635

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

22735

135723

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

52.5

307.7

493

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.6

307.7

2245

7733

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

307.7

4320

18713

A02BC02

ATC

pantoprazole; systemic

4.8

307.7

32505

170314

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

307.7

26737

195011

J01FA09

ATC

clarithromycin; systemic

1.7

307.7

11779

68783

R03BA02

ATC

budesonide; inhalant

1.8

307.7

6644

34545

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

15645

97006

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

307.7

10199

59124

M01AH05

ATC

etoricoxib; oral

1.7

307.7

23852

162350

H02AB06

ATC

prednisolone; systemic

1.9

307.7

19170

113869

K29.8

ICD-10 Finland

Duodenitis

85.9

307.7

375

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

307.7

8771

45424

WX002

NOMESCO Finland

Sedation and analgesia

1.9

307.7

7308

36652

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

6.4

307.7

1230

1706

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.5

307.7

573

770

A02BC04

ATC

rabeprazole; oral

5.5

307.7

6335

11353

K92.0

ICD-10 Finland

Haematemesis

6.3

307.7

1044

1463

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

9115

47118

C07AA05

ATC

propranolol; systemic

1.7

307.7

7333

40044

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

133.4

307.7

398

J02AC01

ATC

fluconazole; systemic

1.7

307.7

15196

90215

A06AD11

ATC

lactulose; oral

1.9

307.7

4988

24126

L08

ICPC

Shoulder symptom/complaint

1.7

307.7

8104

44340

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

201.2

307.7

3174

148

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

307.7

3654

14156

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

2.6

307.7

2576

8870

A02BC03

ATC

lansoprazole; oral

4.0

307.7

16747

53136

K20

ICD-10 Finland

Oesophagitis

20.4

307.7

1099

478

J01DB01

ATC

cefalexin; oral

1.9

307.7

31972

237087

N03AX12

ATC

[U] gabapentin; oral

2.2

307.7

6810

29845

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

23.4

307.7

590

221

R03BB04

ATC

tiotropium bromide; inhalant

2.1

307.7

3691

15914

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

9968

54987

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

20458

141177

N06AA09

ATC

amitriptyline; systemic

2.3

307.7

3804

14919

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

307.7

4412

19161

N06AB04

ATC

citalopram; systemic

1.8

307.7

7926

41051

C07AB07

ATC

bisoprolol; oral

1.7

307.7

17999

112282

R05

ICD-10 Finland

Cough

2.1

307.7

8992

42034

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

87.8

307.7

353

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

307.7

3607

15543

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

307.7

3944

16441

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

132.9

307.7

245

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

307.7

10011

59418

L03

ICPC

Low back symptom/complaint

1.9

307.7

10831

57326

R53

ICD-10 Finland

Malaise and fatigue

1.9

307.7

9167

47379

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

60.5

307.7

642

R00.2

ICD-10 Finland

Palpitations

2.2

307.7

2989

12022

L13

ICPC

Hip symptom/complaint

1.8

307.7

6507

34352

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.5

307.7

2817

7327

6241

FHL

Fund application (Nissen)

168.4

307.7

444

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

24854

177724

SPAT1153

SPAT

Removal of sutures

1.6

307.7

11521

69115

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

7.9

307.7

5028

6148

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

21.2

307.7

27377

33311

L01

ICPC

Neck symptom/complaint

2.0

307.7

6025

28385

A02BDXX, ,

ATC

3.6

307.7

1420

3472

UJF30

NOMESCO Finland

Ileoscopy through colon

3.3

307.7

5207

14868

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

307.7

4626

21326

R11

ICD-10 Finland

Nausea and vomiting

2.7

307.7

3599

12224

XJC10

NOMESCO Finland

Oesophageal pH monitoring

68.1

307.7

652

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

33.2

307.7

1268

340

N03AX16

ATC

[U] pregabalin

2.2

307.7

10099

45962

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

105.9

307.7

244

L17

ICPC

Foot/toe symptom/complaint

1.6

307.7

10479

61259

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

307.7

12860

55539

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

11558

52632

UJF32

NOMESCO Finland

Coloscopy

3.0

307.7

13056

47996

P01AB01

ATC

metronidazole; oral, rectal

1.8

307.7

15518

91664

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

34.6

307.7

433

109

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

6911

34517

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

14758

88544

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

16901

109429

R07.3

ICD-10 Finland

Other chest pain

2.5

307.7

4325

16201

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

307.7

897

1830

N06AX16

ATC

venlafaxine; oral

1.9

307.7

5355

25735

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8469

46992

R52.9

ICD-10 Finland

Pain, unspecified

2.1

307.7

3836

16268

UJD02

NOMESCO Finland

Gastroscopy

10.1

307.7

3482

3238

K29.1

ICD-10 Finland

Other acute gastritis

20.1

307.7

558

243

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

11193

59916

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

16086

99735

M79.1

ICD-10 Finland

Myalgia

2.1

307.7

5702

25884

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

307.7

7385

38005

M01AX17

ATC

nimesulide; oral

1.7

307.7

8651

48630

G44.2

ICD-10 Finland

Tension-type headache

2.4

307.7

5887

23482

K29.4

ICD-10 Finland

Chronic atrophic gastritis

12.4

307.7

473

334

R01AD58

ATC

fluticasone, combinations; nasal

1.7

307.7

8962

51134

A02BA04

ATC

nizatidine; systemic

3.1

307.7

3401

10084

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

307.7

7816

43236

D01

ICPC

Abdominal pain/cramps general

2.2

307.7

4568

18824

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

307.7

1432

4000

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

307.7

15582

101497

N05BA04

ATC

oxazepam; oral

1.8

307.7

9847

53183

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

307.7

5396

22521

M02AA07

ATC

piroxicam; topical

1.6

307.7

13048

80526

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

16092

98157

R05

ICPC

Cough

1.7

307.7

8771

49474

K44

ICD-10 Finland

Diaphragmatic hernia

8.3

307.7

537

567

A02BA03

ATC

famotidine; systemic

3.6

307.7

1610

4011

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

307.7

17778

75652

SPAT1263

SPAT

Sampling

1.7

307.7

16037

97048

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

307.7

5519

23416

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

119.4

307.7

234

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

8785

44752

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

9.2

307.7

577

548

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

14481

79790

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

168.9

307.7

22902

2793

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

9211

49301

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

164.7

307.7

190

J01FA10

ATC

azithromycin; systemic

1.6

307.7

21382

146442

R03BA05

ATC

fluticasone; inhalant

1.9

307.7

7271

35357

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

307.7

12130

50344

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

9116

44815

M03BX02

ATC

tizanidine; oral

1.7

307.7

24214

163392

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

307.7

8552

43719

J01FA06

ATC

roxithromycin; oral

1.6

307.7

14514

92405

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

12490

70185

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

307.7

2711

7892

N05CF01

ATC

zopiclone; oral

1.7

307.7

11946

69126

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

7018

36104

N06AX21

ATC

duloxetine; oral

2.3

307.7

4974

19769

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

11615

69919

A02BA02

ATC

ranitidine; systemic

3.8

307.7

10882

31027

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

307.7

6881

33211

R51.80

ICD-10 Finland

Headache

2.3

307.7

6516

26897

R01AD09

ATC

mometasone; nasal

1.7

307.7

17583

108920

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

12277

70875

J01AA02

ATC

doxycycline; systemic

1.9

307.7

30173

216085

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

17728

99554

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

307.7

19561

130520

K30

ICD-10 Finland

Functional dyspepsia

6.2

307.7

6619

10664

J37.0

ICD-10 Finland

Chronic laryngitis

4.7

307.7

1839

3528

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

307.7

9678

53323

R12

ICD-10 Finland

Heartburn

4.6

307.7

5134

10797

K22.2

ICD-10 Finland

Oesophageal obstruction

109.1

307.7

549

M01AC06

ATC

meloxicam; systemic, rectal

1.6

307.7

13249

82744

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

18832

104548

D06

ICPC

Abdominal pain localized other

2.1

307.4

3188

13553

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

306.4

2722

10877

K59.0

ICD-10 Finland

Constipation

2.5

305.6

2096

7466

XG410

NOMESCO Finland

Flow-volume spirometry

2.9

303.9

1578

4878

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

303.6

4233

20010

C01DA14

ATC

isosorbide mononitrate; oral

1.8

303.5

4917

24399

SFA10

NOMESCO Finland

One-surface restoration

1.5

302.5

19882

138351

J01DA01

ATC

[U] cefalexin

1.5

299.3

22526

160911

J45

ICD-10 Finland

Asthma

2.0

296.9

3862

17824

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

295.2

7560

42670

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

294.7

2291

8640

K44.0

ICD-10 Finland

Diaphragmatic hernia with obstruction, without gangrene

13.0

293.7

306

204

C03CA01

ATC

furosemide; systemic

1.6

293.5

9667

58003

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

287.3

10466

64197

J01FF01

ATC

clindamycin; systemic

1.6

286.2

9701

58533

L15

ICPC

Knee symptom/complaint

1.6

285.8

8458

49428

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

285.1

4450

21796

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

284.5

1593

5125

A01AB09

ATC

miconazole; local oral

2.1

282.8

3116

13537

M54.2

ICD-10 Finland

Cervicalgia

2.1

278.3

2928

12498

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

277.5

1382

4172

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

276.7

3177

14010

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

274.4

1946

7034

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

274.2

10653

66146

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

274.2

1762

6077

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

272.7

4364

21523

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

272.4

1406

4329

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

271.1

7515

43148

C10AA05

ATC

atorvastatin; oral

1.5

269.5

14431

95665

C08CA01

ATC

amlodipine; oral

1.5

269.4

13085

85063

N05AH04

ATC

quetiapine; oral

1.7

268.7

6084

33158

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

268.2

12818

83038

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

267.5

3348

15218

C10AC01

ATC

colestyramine; oral

3.3

267.4

1097

2953

M48.0

ICD-10 Finland

Spinal stenosis

1.8

266.8

4236

20831

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

266.2

2322

9192

M01AX05

ATC

glucosamine; oral

1.7

264.7

6522

36326

G04BD12

ATC

mirabegron; oral

1.9

264.6

4122

20146

SPAT1097

SPAT

Recording of ECG

1.8

263.7

5094

26557

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

262.5

5605

30049

SPAT1310

SPAT

Counselling related to known health issue

1.5

261.6

11109

70152

XQ800

NOMESCO Finland

Prick test

2.1

260.3

2684

11358

C10AA01

ATC

simvastatin; oral

1.5

260.2

14091

93435

R4110, ,

SPAT

2.0

259.2

3159

14219

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

259.0

2702

11486

SPAT1301

SPAT

No procedures

1.5

258.6

10854

68342

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

257.9

8230

48784

R06AX27

ATC

desloratadine; oral

1.5

257.6

10021

62077

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

30.7

257.2

188

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

255.8

2702

11539

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

255.1

10705

67361

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

254.7

23983

176124

N02BF01

ATC

gabapentin; oral

2.0

254.7

2938

12963

N06AB10

ATC

escitalopram; oral

1.6

252.1

7104

40859

A04

ICPC

Weakness/tiredness general

1.7

251.4

4977

26101

N05BA12

ATC

alprazolam; oral

1.9

251.0

3550

16803

SPAT1058

SPAT

PEF monitoring instruction

2.0

249.5

2905

12857

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

248.9

1440

4708

R35

ICD-10 Finland

Polyuria

2.2

248.4

2424

10036

R49.01

ICD-10 Finland

Functional dysphonia

3.0

247.8

1199

3559

R52.2

ICD-10 Finland

Other chronic pain

2.7

247.2

1385

4453

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

5.1

247.0

557

961

J01EA01

ATC

trimethoprim; systemic

1.5

246.4

8849

53785

SPAT1312

SPAT

General health counselling

1.5

246.3

10940

69548

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

245.9

5523

29968

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

244.8

1876

7017

N17

ICPC

Vertigo/dizziness

1.8

244.2

4160

20869

N05BA01

ATC

diazepam; systemic, rectal

1.8

244.2

4464

22869

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.5

243.5

1611

5630

E0000UV, ,

ATC

1.4

242.3

14589

98323

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

242.3

3157

14530

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

241.5

3241

15066

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

240.8

2696

11757

N05CF02

ATC

zolpidem; oral

1.6

239.7

6142

34459

R21

ICPC

Throat symptom/complaint

1.6

238.9

6987

40482

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

238.3

12777

84175

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

234.7

4160

21104

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

233.9

3597

17471

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

233.5

13748

92088

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

233.4

10328

65462

N06AB03

ATC

fluoxetine; oral

1.8

231.5

4259

21835

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

231.5

2549

11042

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

229.8

5118

27667

K02.1

ICD-10 Finland

Caries of dentine

1.4

229.6

20921

151329

L02

ICPC

Back symptom/complaint

1.9

229.1

3449

16635

J20

ICD-10 Finland

Acute bronchitis

1.8

228.8

3633

17818

WX320

NOMESCO Finland

Spinalanesthesy

1.5

227.6

8300

50479

N30.0

ICD-10 Finland

Acute cystitis

1.7

227.2

5450

30031

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

226.8

3987

20164

N01

ICPC

Headache

1.8

226.0

3569

17471

R74

ICPC

Upper respiratory infection acute

1.5

225.2

10702

68703

SFA20

NOMESCO Finland

Two-surface restoration

1.4

225.2

20911

151525

C07AB02

ATC

metoprolol; systemic

1.6

224.9

6492

37435

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

224.6

5132

27915

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

223.9

1805

6899

R03BA01

ATC

beclometasone; inhalant

1.7

223.7

4865

26118

K22.5

ICD-10 Finland

Diverticulum of oesophagus, acquired

95.9

223.5

133

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

223.0

6604

38303

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.0

222.8

2526

11056

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

222.7

1927

7589

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

222.7

4893

26338

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

221.9

8893

55132

K22.0

ICD-10 Finland

Achalasia of cardia

338.0

220.2

235

H25.8

ICD-10 Finland

Other senile cataract

1.8

219.6

3450

16854

N05CD07

ATC

temazepam; oral

1.8

219.1

3818

19248

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

218.0

4808

25894

A07EA06

ATC

budesonide; oral, local oral

2.6

217.9

1352

4576

J01CA08

ATC

pivmecillinam; oral

1.4

217.2

13424

90392

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

216.7

2223

9370

N04BC05

ATC

pramipexole; oral

2.0

216.3

2633

11818

D11

ICPC

Diarrhoea

1.8

215.2

3951

20220

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

214.8

8653

53641

R03AC03

ATC

terbutaline; inhalant

1.7

213.9

4756

25659

SPAT1254

SPAT

Administration of medicine

1.7

212.6

4856

26382

D07AC01

ATC

betamethasone; topical

1.4

212.3

12496

83316

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

212.2

2710

12365

G04BD08

ATC

solifenacin; oral

2.1

212.1

2274

9744

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

210.1

13397

90569

SPAT1260

SPAT

Consultation of another employee

1.6

210.0

6038

34724

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

207.7

2611

11847

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

207.2

2839

13262

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

206.3

4424

23623

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

206.2

3153

15259

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

206.0

3365

16622

M02AA10

ATC

ketoprofen; topical

1.6

204.7

5446

30725

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

204.4

3524

17691

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

203.5

7997

49235

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

203.4

1030

3134

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

202.7

13387

90910

N02BF02

ATC

pregabalin; oral

2.1

202.3

2057

8635

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

201.6

3727

19089

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

200.9

1721

6744

JBB01

NOMESCO Finland

Laparoscopic repair of paraoesophageal hernia

9.5

200.5

256

235

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

4.3

199.9

540

1084

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

198.8

2990

14389

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

198.5

15065

104647

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

198.0

9530

61036

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

196.8

2139

9206

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

196.8

2328

10334

R60.0

ICD-10 Finland

Localized oedema

1.7

196.8

4063

21457

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

196.7

4370

23534

SPAT1104

SPAT

Monitoring of emergency patient

2.0

196.2

2240

9816

D84

ICPC

Oesophagus disease

11.3

195.5

221

169

R06.5

ICD-10 Finland

Mouth breathing

1.8

195.1

3143

15448

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

194.6

2904

13936

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

194.4

2391

10759

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

193.6

1022

3180

M54

ICD-10 Finland

Dorsalgia

1.7

193.4

4216

22586

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

193.4

8530

53674

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

192.9

2378

10707

L28

ICPC

Limited function/disability (L)

1.6

192.7

5648

32563

C09CA06

ATC

candesartan; oral

1.5

192.6

8142

50794

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

192.6

2922

14095

SFA30

NOMESCO Finland

Three-surface restoration

1.4

191.8

14764

102619

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

191.5

7844

48619

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

191.4

3165

15675

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

190.8

9931

64464

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

189.9

4851

27053

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

189.9

3371

17049

C10AA07

ATC

rosuvastatin; oral

1.4

189.6

10776

71059

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

189.6

6751

40632

N03AE01

ATC

clonazepam; systemic

2.1

189.4

1935

8134

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

188.7

1549

5959

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

188.4

2743

13055

R49.08

ICD-10 Finland

Other specified dysphonia

3.1

188.1

855

2446

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

186.3

2457

11318

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

186.1

9257

59531

N06AB06

ATC

sertraline; oral

1.7

185.7

3712

19410

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

185.2

6771

40956

R03AC12

ATC

salmeterol; inhalant

2.3

184.1

1522

5873

U02

ICPC

Urinary frequency/urgency

1.6

184.0

4573

25314

K07.60

ICD-10 Finland

Snapping jaw

2.2

183.3

1752

7174

JBB97

NOMESCO Finland

Laparoscopic repair of other diaphragmatic hernia

21.4

183.2

151

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

183.0

6707

40577

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

182.0

3852

20452

J01MA01

ATC

ofloxacin; systemic

1.9

181.2

2732

13142

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

181.0

3459

17856

G04CA02

ATC

tamsulosin; oral

1.5

180.7

7309

45114

B01AB05

ATC

enoxaparin; parenteral

1.4

180.5

10548

69774

L16

ICPC

Ankle symptom/complaint

1.7

180.1

3751

19826

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

180.1

183

S06.0

ICD-10 Finland

Concussion

1.7

179.2

3561

18581

R51

ICD-10 Finland

Headache

2.1

179.1

1883

7998

N39.3

ICD-10 Finland

Stress incontinence

1.9

179.1

2450

11420

A01AB04

ATC

amphotericin B; local oral

2.2

179.0

1552

6108

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.3

178.9

1456

5580

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

177.9

2074

9149

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.8

177.2

575

1324

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

177.0

2731

13229

N02AA05

ATC

oxycodone; systemic

1.6

176.7

5492

32033

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

176.5

1913

8217

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

3.1

176.4

777

2182

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

176.2

5174

29787

K58

ICD-10 Finland

Irritable bowel syndrome

2.8

175.4

936

2929

D82

ICPC

Teeth/gum disease

1.4

174.6

12444

85036

R06AX22

ATC

ebastine; oral

1.5

174.3

5762

34061

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

173.1

1426

5492

SPAT1211

SPAT

Application of soft bandage

1.8

172.9

2906

14446

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.9

171.7

327

481

H03AA01

ATC

levothyroxine sodium; systemic

1.5

171.3

7677

48283

K08.80

ICD-10 Finland

Toothache NOS

1.8

171.3

2954

14795

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

171.2

3597

19043

SPAT1325

SPAT

Vaccination

1.4

171.2

10924

73228

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

171.1

1503

5946

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

170.5

1371

5225

N41.1

ICD-10 Finland

Chronic prostatitis

2.8

169.8

880

2710

N81.6

ICD-10 Finland

Rectocele

2.0

169.1

2148

9761

G04CA01

ATC

alfuzosin; oral

1.7

168.6

3911

21245

L04

ICPC

Chest symptom/complaint

2.0

168.6

2067

9278

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

168.3

1836

7903

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

168.0

1026

3442

L12

ICPC

Hand/finger symptom/complaint

1.5

167.8

5293

30942

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

167.6

2913

14620

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

167.2

1900

8302

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

166.8

2196

10100

XKD00

NOMESCO Finland

Uroflowmetry

1.6

166.7

4938

28455

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.4

166.5

631

1614

J01MA06

ATC

norfloxacin; oral

1.6

166.2

4231

23521

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

166.1

1941

8565

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

165.6

5457

32199

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

165.4

3741

20184

R06.2

ICD-10 Finland

Wheezing

2.2

165.4

1536

6214

SPAT1240

SPAT

Therapeutic discussion

1.7

165.2

3323

17379

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

165.1

7658

48432

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

163.9

4603

26191

R51.81

ICD-10 Finland

Facial pain NOS

2.8

163.5

858

2660

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

163.3

10963

73985

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

163.3

3994

21978

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

163.1

3002

15313

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

162.5

2147

9884

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

161.9

2940

14937

UJD10, ,

SPAT

2.9

161.4

805

2427

I20.09

ICD-10 Finland

Unstable angina

2.1

161.2

1739

7453

K29.2

ICD-10 Finland

Alcoholic gastritis

52.9

161.0

104

X58

ICD-10 Finland

Exposure to other specified factors

1.6

160.8

4678

26828

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

159.5

4112

22913

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

159.4

6526

40253

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

158.7

8203

52873

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

157.9

8452

54809

WX290

NOMESCO Finland

Other blockage of nerve

1.3

157.4

15723

112709

R55

ICD-10 Finland

Syncope and collapse

1.7

156.4

3486

18723

R03AC13

ATC

formoterol; inhalant

2.1

156.3

1666

7106

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

156.0

1950

8806

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

156.0

4216

23753

H92.0

ICD-10 Finland

Otalgia

1.9

155.2

2001

9132

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

155.1

1087

3894

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027945) Reticulocytes/100 erythrocytes in Blood

5313

26527

1.84

323.31

2.5

2.6

1.76

1.73

1.03

4570

23596

(3035350) Ketones [Presence] in Urine by Test strip

19216

131743

1.51

323.01

4.3

3.4

0.00

estimate

0.48

3773

26695

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7422

40973

1.69

318.40

3.5

3.4

0.81

0.82

mmol/l

3.25

6891

38319

(40761511) CBC panel - Blood by Automated count

36198

288646

2.07

312.23

18.3

11.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33438

251463

2.00

307.65

6.7

5.4

39.93

39.55

mmol/mol

11.11

30680

233410

(3013707) Erythrocyte sedimentation rate by Westergren method

30885

198805

2.61

307.65

5.2

3.8

11.81

11.85

mm/h

0.20

28593

184243

(3037522) Nuclear Ab [Titer] in Serum

7183

34849

1.95

307.65

1.4

1.3

586.33

522.57

titre

1.79

1615

6961

(40768804) Tissue Pathology biopsy report

17178

109552

1.63

307.65

2.2

2.0

—

(36660697) Celiac disease serology panel - Serum

4363

19520

2.04

307.65

1.2

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6730

33138

1.91

307.65

2.8

2.5

22.28

23.18

5.46

5650

28385

(3006504) Eosinophils/100 leukocytes in Blood

20807

123745

1.96

307.65

6.6

5.9

2.91

2.86

2.34

19365

115980

(3044640) Blood type and Crossmatch panel - Blood

13988

81929

1.74

307.65

2.6

2.3

—

(3013115) Eosinophils [#/volume] in Blood

22560

136588

2.00

307.65

6.6

6.0

0.20

0.19

e9/l

1.05

20087

119689

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

17070

77652

2.59

307.65

3.0

2.4

59.58

60.71

u/l

0.28

15725

71565

(3019225) pH of Specimen

6140

23918

2.44

307.65

4.3

4.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2574

9548

2.42

307.65

4.3

3.9

24.77

24.84

mmol/l

0.67

2397

8832

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9503

54002

1.68

307.65

1.7

1.6

75448690.09

28826762.77

pmol/l

5.85

7808

44723

(3019069) Monocytes/100 leukocytes in Blood

20889

124522

1.96

307.65

7.0

6.2

8.45

8.56

5.99

19471

116884

(3021960) Folate [Moles/volume] in Serum or Plasma

10869

56708

1.90

307.65

1.6

1.5

21.01

20.30

nmol/l

3.31

9092

48744

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

34606

266153

2.04

307.65

5.4

4.3

5.97

5.91

mmol/l

12.87

31370

244214

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

26661

181490

1.84

307.65

4.0

2.9

51.22

46.99

u/l

9.18

24779

169766

(3022313) Gas panel - Capillary blood

2815

11006

2.30

307.65

4.1

3.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

31763

205743

2.75

307.65

8.7

7.1

77.90

77.98

u/l

0.11

30103

193770

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12312

60447

2.10

307.65

2.6

2.1

2.99

2.88

mg/l

5.16

10514

51483

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14269

86207

1.67

307.65

3.5

3.1

33.69

33.47

u/l

0.08

13465

81715

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

34281

251752

2.40

307.65

5.8

4.5

1.88

2.16

mu/l

5.62

31385

231521

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10485

56717

1.81

307.65

1.9

1.7

1.05

1.22

mg/l

6.33

7763

43469

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

18582

103558

2.04

307.65

2.2

1.9

99.07

96.22

pmol/l

10.86

9676

53755

(40760892) CBC W Ordered Manual Differential panel - Blood

20879

124046

1.97

307.65

7.0

6.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14109

77861

1.88

307.65

2.3

2.1

174.16

212.31

u/l

4.02

13262

72928

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18890

111736

1.88

307.65

3.4

2.7

121.74

130.60

ug/l

3.20

17353

103779

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5751

28091

1.90

307.65

2.7

2.6

7.23

8.64

umol/l

5.78

4974

24318

(3023103) Potassium [Moles/volume] in Serum or Plasma

36746

284077

2.87

307.65

21.0

14.7

3.97

mmol/l

0.82

35949

276383

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7217

30919

2.24

307.65

4.8

4.3

32.44

32.12

1.54

5100

21456

(3026008) Bacteria identified in Urine by Culture

12643

77654

1.60

307.65

3.4

2.9

—

(3018010) Neutrophils/100 leukocytes in Blood

21042

126213

1.95

307.65

6.4

5.8

56.78

57.14

4.27

19609

118743

(3019309) Folate [Moles/volume] in Red Blood Cells

9316

44621

2.05

307.65

1.8

1.7

1100.83

1181.89

nmol/l

13.94

6953

33704

(3048689) Calprotectin [Mass/mass] in Stool

7484

29328

2.48

307.65

2.5

2.3

131.55

132.16

ug/g

0.05

5864

23062

(3007164) IgA [Mass/volume] in Serum or Plasma

10041

47663

2.10

307.65

1.5

1.4

2.39

2.38

g/l

0.18

5878

29410

(3020564) Creatinine [Moles/volume] in Serum or Plasma

36834

295083

2.28

307.65

21.1

14.9

78.80

76.48

umol/l

25.72

36814

294966

(3022948) Iron [Moles/volume] in Serum or Plasma

7745

38667

1.91

307.65

2.7

2.4

13.12

13.94

umol/l

0.89

7172

36058

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8584

48877

1.66

307.65

4.5

3.4

341.40

555.51

ng/l

3.78

6320

37338

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17770

96465

2.08

307.65

4.3

3.2

41.62

68.20

ng/l

2.33

12022

63986

(3006315) Basophils [#/volume] in Blood

21808

132234

1.95

307.65

6.4

5.7

0.04

e9/l

1.77

19305

114152

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19968

116690

1.97

307.65

6.5

5.7

1.22

1.21

mmol/l

8.56

17862

106685

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2141

6246

3.07

307.65

1.5

1.4

285.80

272.08

ug/g

2.06

1196

3623

(3001604) Monocytes [#/volume] in Blood

21726

131959

1.94

307.65

6.4

5.7

0.58

e9/l

0.60

19274

114019

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8453

45395

1.77

307.65

1.3

27.49

37.76

iu/ml

5.34

2594

14787

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3237

12236

2.40

307.65

2.6

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

36710

283162

2.88

307.65

20.8

14.5

139.63

139.71

mmol/l

8.49

35977

275981

(40768797) Stomach Pathology biopsy report

14718

23704

7.98

307.65

1.3

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18125

107893

1.84

307.65

2.6

2.2

77.78

917.85

nmol/l

0.50

16056

97534

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

37045

295689

2.48

307.65

13.3

9.6

26.61

26.52

u/l

0.35

35870

285435

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

410

370

9.65

307.65

1.0

—

(3009343) pH of Capillary blood

3672

15280

2.18

307.65

4.0

3.6

7.41

7.42

0.66

394

2046

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

30031

208785

2.03

307.65

4.7

3.9

14.81

14.73

pmol/l

6.54

27244

190639

(3024561) Albumin [Mass/volume] in Serum or Plasma

18965

111270

1.91

307.65

5.2

4.6

35.82

35.63

g/l

4.73

17569

103165

(3005719) IgG [Mass/volume] in Serum or Plasma

4108

18430

2.03

307.65

2.7

10.34

10.55

g/l

2.22

3739

16876

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11056

61909

1.75

307.65

2.5

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19041

124470

1.62

307.65

2.9

2.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

23989

133558

2.42

307.65

6.1

6.0

10.70

11.49

umol/l

19.44

22756

126581

(3009261) Glucose [Presence] in Urine by Test strip

19432

133187

1.51

307.65

4.3

3.4

0.01

0.00

estimate

0.25

3488

24630

(3022145) Colonoscopy Study observation

6722

27513

2.34

307.65

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8003

42778

1.77

307.65

1.3

9.78

11.97

u/ml

1.73

2731

17182

(4200892) Spirometry reversibility

4074

18054

2.06

307.65

1.5

1.4

—

(3022096) Basophils/100 leukocytes in Blood

20106

119877

1.92

307.65

6.6

6.0

0.69

0.68

1.83

18640

112015

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

33786

260271

1.87

307.65

16.3

12.1

80.37

82.04

ml/min/173m2

39.21

28836

214032

(3022217) INR in Platelet poor plasma by Coagulation assay

20367

120050

1.96

307.65

14.3

14.0

1.21

1.26

inr

8.47

5938

35348

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13146

70233

1.92

307.65

3.1

2.9

1252.27

1345.64

ng/l

1.30

10822

59976

(3013139) Helicobacter pylori Ag [Presence] in Stool

4483

14648

2.85

307.65

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4820

22518

1.96

307.65

2.1

2.3

362.26

375.85

nmol/l

3.86

4379

20814

(3015377) Calcium [Moles/volume] in Serum or Plasma

14312

87863

1.64

307.65

3.0

3.4

2.35

2.36

mmol/l

7.80

12113

77835

(3019198) Lymphocytes [#/volume] in Blood

22208

136122

1.94

307.65

6.4

5.8

1.95

1.94

e9/l

0.33

20069

120212

(3037467) Urinalysis macro (dipstick) panel - Urine

28073

183681

2.12

307.65

5.3

4.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3715

15483

2.18

307.65

4.0

3.6

5.11

5.15

kpa

1.92

3506

14641

(3013650) Neutrophils [#/volume] in Blood by Automated count

23995

153610

1.90

307.65

9.0

4.07

4.10

e9/l

0.96

21392

133706

(3002030) Lymphocytes/100 leukocytes in Blood

21311

128269

1.95

307.65

6.8

6.0

28.21

28.06

1.16

19911

120720

(3013826) Glucose [Moles/volume] in Serum or Plasma

24500

154499

1.98

307.65

5.3

4.4

6.63

6.71

mmol/l

6.84

23186

144207

(3013512) EKG study

14433

73417

2.10

307.65

4.5

3.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7189

35561

1.91

307.65

2.7

2.4

2.39

2.33

g/l

16.46

6597

32873

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3557

14751

2.19

307.65

3.9

3.6

1.40

1.75

mmol/l

6.90

2688

10869

(3005322) IgE [Units/volume] in Serum or Plasma

3688

15947

2.10

307.65

1.4

1.3

175.27

252.54

u/ml

4.66

3439

14786

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11495

54952

2.14

307.65

1.4

1.3

1.69

1.68

u/ml

0.05

2776

15327

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3906

17141

2.07

307.65

1.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2953

7584

3.55

307.65

1.6

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

26610

174053

1.99

307.65

5.5

4.1

914.00

1391.70

e6/l

1.12

263

2584

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

36326

275380

2.89

307.65

18.9

12.7

20.30

23.99

mg/l

91.12

30609

215388

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7374

40198

1.72

307.65

2.0

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

21582

129065

1.98

307.65

7.5

6.4

1.22

1.21

mmol/l

4.96

18205

109388

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4683

22809

1.88

306.84

2.4

2.1

0.22

g/l

2.78

4362

21206

(3021601) Nitrite [Presence] in Urine by Test strip

19128

131894

1.49

305.96

5.8

4.6

0.00

estimate

0.07

3614

25315

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3003

12560

2.15

301.76

1.1

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3262

14132

2.08

298.98

1.9

1.33

1.31

g/l

0.18

2949

12892

(3015736) pH of Urine

15852

105859

1.49

292.53

3.8

3.2

5.80

5.85

1.07

1093

8440

(3023368) Bacteria identified in Blood by Culture

11137

69077

1.55

291.74

4.6

4.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

11315

70465

1.54

290.82

2.8

2.5

3102.82

4350.71

umol/l

3.35

9758

62083

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6042

32520

1.71

280.67

6.5

5.7

1.04

mmol/l

1.19

5618

30279

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

35073

278765

1.81

271.15

5.7

4.7

2.73

2.80

mmol/l

39.01

32123

258504

(3023520) Reticulocytes [#/volume] in Blood

4052

19577

1.88

270.06

2.6

68.89

69.22

e9/l

0.23

3193

14584

(3017732) Neutrophils [#/volume] in Blood

3774

17824

1.91

269.63

3.0

2.7

4.50

4.99

e9/l

1.63

2804

14574

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

33450

262516

1.68

268.69

4.6

3.8

1.34

1.29

mmol/l

25.75

30442

241817

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

34582

274027

1.75

265.62

5.1

4.2

4.63

4.71

mmol/l

39.68

31881

255295

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

34360

271976

1.73

261.93

5.2

4.2

1.44

1.47

mmol/l

25.09

31483

252296

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2461

10122

2.17

256.63

2.0

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3785

18254

1.87

252.75

4.0

3.8

92.49

89.63

ng/l

0.86

3174

15803

(3018418) pH of Serum or Plasma

11938

77004

1.48

251.20

4.5

4.0

7.40

0.42

2346

15008

(3003327) Ova and parasites identified in Stool by Light microscopy

2083

8101

2.29

248.64

1.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

5534

30097

1.68

244.12

1.6

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1483

4997

2.62

241.45

1.4

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5207

28118

1.69

235.16

3.6

4.4

233.61

245.70

u/l

10.05

4846

26678

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4407

22821

1.75

231.39

2.8

2.3

35.56

45.69

u/l

1.65

3737

19501

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1012

2839

3.13

230.34

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1011

2835

3.13

230.27

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1021

2882

3.11

229.98

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1009

2836

3.12

228.91

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1036

2958

3.08

228.88

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1018

2878

3.11

228.70

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

12347

81364

1.45

227.26

4.0

3.8

9.68

8.46

mg/mmol

1.67

7422

51326

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2224

9298

2.13

221.58

1.9

1.8

—

(3018095) Leukocytes [#/volume] in Urine

13794

93217

1.43

219.42

4.3

3.5

75.17

101.64

e6/l

4.22

10212

65167

(3025941) Bacteria identified in Stool by Culture

3074

14522

1.90

217.22

1.3

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

12464

82906

1.44

215.27

3.4

3.2

7.41

7.72

mmol/l

11.12

10216

70291

(3009542) Hematocrit [Volume Fraction] of Blood

37659

309754

2.26

210.35

28.2

18.8

39.97

40.58

19.13

35524

290673

(3007461) Platelets [#/volume] in Blood

37681

310038

2.27

209.71

28.1

18.8

254.36

251.90

e9/l

10.87

37080

301598

(3012516) Albumin [Mass/volume] in Urine

11715

77351

1.44

209.21

3.4

3.2

552.65

372.80

mg/l

2.78

7080

49136

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1751

6823

2.27

207.31

1.3

1.2

27.09

37.98

u/ml

1.12

425

(3033658) Prothrombin time (PT) actual/Normal

10378

67149

1.45

205.89

4.5

3.7

91.98

90.73

5.30

10113

65492

(3035941) MCH [Entitic mass]

37681

310255

2.25

205.08

28.0

18.7

30.24

30.31

13.36

37288

305879

(3024731) MCV [Entitic volume]

37683

310301

2.25

204.60

28.0

18.7

90.93

90.95

0.36

37292

305903

(3004616) Nuclear Ab [Presence] in Serum

977

2880

2.98

204.12

1.3

—

(3010813) Leukocytes [#/volume] in Blood

37684

310342

2.24

203.97

28.1

18.8

6.77

6.68

e9/l

9.15

36985

300968

(3026361) Erythrocytes [#/volume] in Blood

37682

310324

2.24

203.87

28.1

18.8

4.48

4.52

e12/l

47.63

36991

300991

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7666

46773

1.51

203.77

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1644

6285

2.31

203.47

1.3

8.72

7.79

u/ml

0.23

293

975

(3000963) Hemoglobin [Mass/volume] in Blood

37685

310418

2.24

202.61

28.3

18.9

134.44

136.15

g/l

100.88

37288

306048

(3002582) Erythrocytes [#/volume] in Urine

11939

79561

1.42

200.64

3.8

3.1

72.22

93.56

e6/l

1.01

9494

60346

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3541

17902

1.78

200.29

2.5

2.3

24.75

23.34

au/ml

0.29

252

1456

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

965

2876

2.94

197.71

2.4

1.9

23.85

27.26

mg/l

0.91

223

792

(3000492) Spirometry study

4747

26128

1.65

196.37

1.6

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1611

6211

2.29

195.39

1.3

1.2

6.70

6.40

u/ml

0.05

193

616

(3026782) Osmolality of Urine

8256

51596

1.48

193.79

3.3

2.8

527.67

545.77

mosm/kgh2o

10.14

7060

44277

(3004588) Protein electrophoresis panel - Serum or Plasma

3250

16198

1.80

192.54

2.2

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

8659

54695

1.47

192.31

2.9

2.5

5.20

5.59

e6/l

2.04

7802

48896

(3020630) Protein [Mass/volume] in Serum or Plasma

3776

20000

1.70

179.93

2.3

2.6

66.66

66.58

g/l

0.25

3400

18236

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3221

16330

1.76

179.49

1.3

48.22

53.74

au/ml

0.64

134

908

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14635

102407

1.37

178.45

4.5

3.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

5281

30501

1.57

177.45

1.9

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1351

5071

2.34

174.04

1.3

1.2

6.71

6.22

u/ml

0.06

107

374

(3042936) Bacteria identified in Isolate by Culture

6082

36457

1.52

172.22

2.2

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

10877

72817

1.40

171.91

3.6

3.0

0.33

0.43

e6/l

5.86

8553

54792

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1645

6772

2.14

169.59

1.1

5.43

5.29

u/ml

0.04

149

930

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2233

10281

1.93

169.11

1.7

1.58

1.55

g/l

0.93

1899

8730

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1335

5053

2.32

168.67

1.3

1.2

8.89

11.05

u/ml

0.17

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1801

7716

2.06

167.19

1.8

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1858

8070

2.03

166.16

2.9

2.5

—

(36304419) Bacteria [Presence] in Urine

10593

71013

1.39

164.52

3.6

2.9

—

(40758558) Short blood count panel - Blood

10076

66979

1.40

164.50

6.5

7.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

1583

6547

2.13

161.14

1.2

100.15

131.18

titre

0.93

137

600

(3034770) Mitochondria Ab [Titer] in Serum

1566

6468

2.13

159.95

1.2

749.79

985.67

titre

0.81

194

(3023419) Bacteria identified in Sputum by Culture

990

3422

2.53

152.40

2.8

2.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1040

3704

2.46

150.28

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7385

47221

1.43

147.75

2.7

3.0

2.44

2.45

mmol/l

5.32

6286

41454

(3019150) Specific gravity of Urine by Refractometry

8597

56587

1.40

145.44

4.6

3.8

1.02

kg/l

0.42

1590

8132

(3038026) Centromere Ab [Units/volume] in Serum

653

1859

3.06

144.78

1.2

33.78

55.19

u/ml

0.91

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

23149

176700

1.32

142.73

3.3

2.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3756

21009

1.60

142.45

2.6

2.2

5.80

7.65

ug/l

8.79

3166

18355

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2115

10130

1.85

141.17

1.3

1.2

1.12

0.72

u/ml

0.73

180

902

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3688

20587

1.60

140.97

3.2

2.8

169.96

200.13

ng/l

4.15

3303

18788

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2766

14346

1.71

140.77

1.8

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

634

1812

3.05

139.63

1.2

65.50

74.02

u/ml

0.25

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

456

1056

3.76

139.41

1.1

6.95

8.48

u/ml

0.43

182

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

634

1818

3.04

138.84

1.2

47.18

47.70

u/ml

0.02

132

(3020961) Endomysium IgA Ab [Titer] in Serum

2374

11840

1.78

138.61

1.1

288.16

202.95

titre

0.50

303

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2076

9969

1.84

137.33

1.1

1.44

7.57

u/ml

1.23

139

(3041096) Erythrocytes [Presence] in Urine by Automated

10534

72190

1.35

137.25

3.9

3.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2184

10689

1.81

135.76

1.9

2.0

39.53

39.27

u/l

0.24

1942

9523

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4437

26085

1.53

134.62

3.2

4.2

16.92

27.22

ug/l

1.90

3470

21012

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6259

39593

1.43

130.85

2.1

29.67

29.80

0.88

6025

38452

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2187

10891

1.78

128.06

1.4

1.6

10.97

16.30

u/ml

0.80

311

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

598

1739

3.00

127.82

1.2

13.23

7.84

u/ml

0.47

108

(3045414) Leukocytes [Presence] in Urine

2268

11460

1.75

126.24

1.9

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3817

22026

1.55

125.52

8.6

7.1

9.73

9.63

mmol/l

0.34

3643

20950

(3024980) IgG subclass 4 [Mass/volume] in Serum

1005

3866

2.27

121.98

1.5

1.6

0.63

0.79

g/l

5.80

738

2906

(3045424) Erythrocytes [Presence] in Urine

1065

4203

2.22

121.57

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4591

27733

1.48

121.28

2.0

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5241

32556

1.45

119.79

7.4

6.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1669

7823

1.88

118.81

1.8

1.6

1.17

1.18

g/l

0.60

1576

7460

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1628

7593

1.89

117.67

1.8

1.6

0.23

g/l

2.21

1531

7214

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6415

41489

1.40

116.70

3.3

2.8

2.85

2.80

e6/l

0.14

3677

22083

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

523

1490

3.05

115.84

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

525

1500

3.05

115.71

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

576

1744

2.88

114.61

1.3

1.27

2.04

u/ml

1.47

335

944

(3011397) Hemoglobin [Presence] in Urine by Test strip

8968

61343

1.34

114.14

4.2

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

4738

29133

1.46

113.77

1.7

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1143

4780

2.09

112.61

1.2

1.3

122.00

140.71

titre

—

113

(3022621) pH of Urine by Test strip

3003

16798

1.59

112.53

3.4

2.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

899

3451

2.28

109.61

1.5

1.3

—

(3044889) 12 lead EKG panel

24556

191887

1.28

109.61

4.3

3.5

—

(3029937) Albumin [Presence] in Urine by Test strip

10204

71442

1.31

109.41

4.8

3.8

0.00

estimate

0.54

3538

24294

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1745

8527

1.80

108.51

2.1

2.3

392.40

525.08

ug/l

1.10

1636

7965

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1435

6601

1.91

108.06

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1729

8458

1.80

107.11

1.6

280.36

275.39

titre

0.03

369

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6755

44642

1.37

106.57

3.1

2.7

1.02

1.19

e6/l

1.38

4000

25078

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4518

27880

1.45

105.86

2.0

1.7

—

(4062490) Immunoglobulin typing, IgG

702

2460

2.49

104.92

1.4

—

(3003396) Base excess in Arterial blood by calculation

4626

28723

1.44

104.79

7.5

7.1

1.11

1.08

mmol/l

0.21

3738

22938

(3028192) IgG subclass 2 [Mass/volume] in Serum

700

2460

2.48

103.99

1.4

2.89

2.94

g/l

0.32

480

1712

(3012544) pH of Venous blood

3954

23864

1.48

103.78

4.5

3.9

7.37

7.38

0.49

167

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4620

28738

1.44

103.53

7.5

7.1

5.04

5.11

kpa

5.16

4387

27457

(3024139) IgG subclass 3 [Mass/volume] in Serum

699

2460

2.48

103.52

1.4

0.38

0.41

g/l

1.29

484

1714

(3027135) IgG subclass 1 [Mass/volume] in Serum

699

2462

2.48

103.35

1.4

6.36

6.86

g/l

2.95

480

1714

(3002032) Base excess in Venous blood by calculation

3820

22917

1.48

103.30

4.6

3.9

1.86

1.89

mmol/l

0.21

3294

19511

(3027801) Oxygen [Partial pressure] in Arterial blood

4615

28721

1.44

103.11

7.5

7.1

11.91

12.60

kpa

16.25

4382

27419

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5097

32329

1.41

102.40

1.9

1.7

1.52

1.43

14.34

4376

28646

(3014111) Lactate [Moles/volume] in Serum or Plasma

3679

21964

1.49

101.83

7.1

6.9

1.33

1.34

mmol/l

0.47

3571

21422

(40768443) Skin Pathology biopsy report

2165

11447

1.67

101.49

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2912

16586

1.56

100.39

3.0

3.4

4.46

4.50

pmol/l

1.08

2511

14853

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1521

7335

1.82

98.64

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

4160

25589

1.45

98.63

7.8

7.5

95.53

95.68

0.77

4012

24639

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1446

6875

1.85

98.17

1.5

18.50

14.10

iu/ml

0.49

177

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10111

71538

1.30

97.99

1.7

1.6

1.44

1.37

mmol/l

9.42

8476

60040

(3037121) Protein [Mass/volume] in Urine

1714

8581

1.76

97.98

3.0

3.3

0.34

0.31

g/l

0.48

614

3903

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1162

5148

1.98

97.64

1.3

1.2

40.56

43.67

u/ml

0.25

115

508

(3014765) Yersinia sp identified in Stool by Organism specific culture

1489

7161

1.82

97.42

1.2

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4967

31621

1.41

97.26

7.6

6.9

104.20

104.50

mmol/l

4.11

4962

31600

(42529406) Shigella sp [Presence] in Stool by Culture

1491

7181

1.82

97.09

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3793

23021

1.47

96.30

4.6

3.9

5.80

5.84

kpa

1.60

3681

22358

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1263

5794

1.91

95.78

1.8

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

3697

22349

1.47

95.77

4.2

4.0

0.89

0.97

0.83

1367

7300

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1473

7101

1.82

95.60

1.2

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

936

3866

2.11

95.19

1.8

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

936

3867

2.11

95.13

1.8

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1782

9141

1.71

93.36

2.0

2.3

7.35

7.37

g/l

0.27

1564

8254

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1777

9114

1.71

93.14

2.0

2.3

3.62

3.74

g/l

2.28

1561

8230

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1776

9136

1.71

92.07

2.0

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1150

5205

1.93

90.76

1.5

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

3525

21327

1.47

90.65

4.2

4.1

0.08

0.13

2.72

1205

6319

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

798

3177

2.19

89.08

1.1

1.51

1.49

g/l

0.54

716

2887

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1401

6843

1.79

86.98

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2553

14599

1.54

85.96

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3372

20447

1.46

85.45

4.0

3.9

0.57

0.69

2.84

1240

6270

(3042631) Mycobacterium sp identified in Specimen

806

3280

2.14

85.15

2.8

2.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3010

17884

1.49

84.51

1.2

112.64

145.44

iu/ml

4.88

1003

6867

(3049717) Cytology report of Urine Cyto stain

1812

9611

1.66

83.55

2.5

2.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

898

3837

2.04

83.43

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1663

8636

1.69

83.11

2.0

2.3

2.83

2.94

g/l

4.55

1445

7750

(3019060) Gas panel - Arterial blood

2790

16378

1.51

83.02

5.0

4.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1644

8526

1.69

82.56

1.9

2.3

10.06

10.20

g/l

0.60

1414

7593

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1189

5634

1.85

81.46

1.8

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

824

3443

2.09

81.29

1.3

0.57

1.18

nmol/l

1.05

797

3326

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

818

3438

2.07

79.45

1.3

0.27

0.23

nmol/l

0.22

228

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

534

1877

2.47

79.35

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

743

3019

2.14

78.81

1.2

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1368

6835

1.75

78.53

1.9

2.1

10.91

10.86

mg/l

0.06

1245

6404

(3044927) Protein electrophoresis panel - Urine

587

2188

2.33

76.65

1.2

—

(4146454) Self-monitoring of blood glucose

668

2634

2.21

76.37

2.8

2.7

—

(3025159) Blasts/100 leukocytes in Blood

3297

20328

1.44

76.03

4.2

4.1

0.29

0.30

0.00

994

5362

(3024354) Oxygen [Partial pressure] in Venous blood

3095

18881

1.45

75.54

4.0

3.3

4.66

4.63

kpa

0.28

2991

18266

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1262

6236

1.77

75.25

3.0

3.1

24.60

24.70

mmol/l

0.42

1225

6111

(3023183) Ammonium ion [Moles/volume] in Plasma

1032

4794

1.88

75.22

2.8

2.4

32.62

32.92

umol/l

0.17

924

4321

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3748

23698

1.40

74.93

8.4

7.8

121.56

122.32

g/l

1.43

3647

23058

(40761535) Cells panel - Urine sediment

3388

21087

1.42

74.06

3.8

3.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

935

4244

1.92

73.11

1.6

1.4

—

(3000991) Gas panel - Venous blood

3390

21175

1.42

72.55

9.0

8.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1046

4940

1.85

72.39

6.8

5.3

655.42

2066.65

iu/ml

0.81

179

686

(3048929) Epstein Barr virus Ab [Presence] in Serum

1448

7533

1.68

71.75

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1476

7735

1.67

71.13

1.7

1.6

9.64

4.83

iu/ml

0.45

297

1627

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1487

7821

1.67

70.67

2.1

2.5

0.70

0.92

g/l

1.52

1230

6729

(3017354) Segmented neutrophils/100 leukocytes in Blood

610

2399

2.21

70.21

3.5

3.2

56.74

56.78

0.01

508

2017

(3003181) Sodium [Moles/volume] in Urine

881

3984

1.93

69.66

1.5

1.4

63.81

63.42

mmol/l

0.09

700

3162

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

388

1243

2.71

69.63

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2320

13592

1.50

69.29

3.0

2.7

0.25

0.28

e6/l

0.61

2262

13194

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

736

3149

2.04

68.15

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

834

3730

1.95

68.13

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5477

37220

1.31

68.02

1.7

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

1281

6549

1.71

67.68

3.0

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

650

2672

2.12

66.95

3.6

3.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

829

3728

1.94

66.64

1.3

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1745

9690

1.58

66.47

2.1

2.0

1.96

2.18

ug/l

0.34

1511

8537

(3021589) Normoblasts [#/volume] in Blood

15800

121257

1.21

66.37

11.2

9.1

0.00

e9/l

0.52

13187

99387

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

441

1543

2.48

66.25

2.6

3.5

91.80

141.37

nmol/l

2.80

430

1522

(3008898) HLA-B27 [Presence]

1603

8741

1.61

65.92

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

871

3999

1.90

65.81

3.5

3.3

1.38

1.52

0.57

754

3569

(3004716) Salmonella sp identified in Stool by Organism specific culture

2196

12881

1.50

65.10

1.4

—

(3047181) Lactate [Moles/volume] in Blood

1474

7899

1.63

65.04

5.7

5.6

1.30

mmol/l

0.11

1316

6999

(3004119) Hemoglobin [Mass/volume] in Venous blood

2464

14811

1.46

64.60

4.0

3.3

128.23

130.19

g/l

4.09

2392

14479

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

476

1757

2.35

63.63

1.1

285.29

459.31

mg/l

0.53

407

1598

(46235355) HIV 1 and 2 tests - Meaningful Use set

6408

44807

1.28

63.53

1.9

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2285

13607

1.48

62.79

9.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

800

3633

1.92

62.48

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

750

3338

1.96

62.16

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2561

15622

1.44

62.06

7.3

6.9

24.50

24.64

mmol/l

1.17

2434

14872

(3016244) Insulin [Units/volume] in Serum or Plasma

416

1463

2.47

61.85

2.9

3.3

27.15

27.16

mu/l

0.00

393

1375

(3002256) Pathology report gross observation

5232

35750

1.30

61.85

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

1346

7155

1.64

61.30

1.1

—

(21494755) Public health laboratory ask at order entry panel

2416

29120

0.70

61.01

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

367

1226

2.60

60.72

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

367

1226

2.60

60.72

1.7

1.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2011

11754

1.50

60.55

4.1

3.3

25.18

25.29

mmol/l

0.77

1948

11384

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1001

4938

1.77

59.98

2.8

3.4

546.76

944.57

u/ml

0.51

894

4496

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1399

7555

1.62

59.81

2.9

3.5

49.33

41.19

mg/l

0.38

1135

6075

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1793

10280

1.53

59.11

5.2

4.8

1.69

1.68

0.14

1686

9638

(3034860) Kappa light chains.free [Mass/volume] in Serum

1398

7573

1.61

59.01

2.9

3.5

48.15

56.86

mg/l

0.88

1135

6082

(3017315) Amylase [Enzymatic activity/volume] in Urine

369

1254

2.55

58.97

1.2

278.20

336.04

u/l

0.30

335

1182

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1330

7138

1.63

58.29

1.8

2.3

38.04

37.88

g/l

0.40

1105

6241

(3007930) Methemoglobin/Hemoglobin.total in Blood

1762

10106

1.53

57.97

5.3

4.9

0.90

0.89

0.35

1661

9463

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4424

29792

1.32

57.86

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4019

26724

1.33

57.44

3.7

3.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

625

2690

2.02

56.99

2.8

3.4

7.05

7.60

nmol/l

0.07

598

2622

(3006462) Nitrate [Presence] in Urine

340

1129

2.61

56.97

4.1

2.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1354

7351

1.61

56.61

2.9

3.4

8.08

4.00

ratio

0.34

605

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11497

86600

1.21

55.99

5.2

4.8

2.58

3.29

ug/l

2.73

10285

77956

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1120

5815

1.68

55.84

2.3

2.1

130.30

130.73

g/l

0.20

793

4282

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

610

2632

2.01

55.25

1.2

58.46

64.12

u/l

0.64

553

2357

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

505

2034

2.16

54.88

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

505

2034

2.16

54.88

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

505

2034

2.16

54.88

1.6

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

541

2244

2.09

54.51

3.8

3.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1142

6000

1.66

54.41

4.3

3.5

8.42

8.34

kpa

0.92

1113

5859

(3032057) Clostridioides difficile [Presence] in Stool

182

432

3.65

54.01

1.9

1.7

—

(40761536) Microorganisms panel - Urine sediment

3489

22921

1.34

53.94

4.8

3.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1160

6137

1.65

53.80

1.7

1.6

10394.41

13719.43

e6/l

2.44

847

4484

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

867

4242

1.78

53.44

1.8

1.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

327

1104

2.57

53.02

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

327

1104

2.57

53.02

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

263

793

2.87

52.99

1.3

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

138

273

4.37

52.34

1.6

1.8

38.33

36.97

pmol/l

0.06

110

223

(3010838) Calcium [Moles/time] in 24 hour Urine

915

4592

1.74

51.65

1.9

4.79

5.29

mmol/24h

4.58

777

4094

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

591

2593

1.98

51.10

1.7

—

(4035726) Immunohistochemistry procedure

3545

23529

1.33

50.95

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

819

4000

1.78

50.80

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

686

3176

1.88

50.58

1.5

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

679

3135

1.88

50.49

1.3

1.2

79.76

44.77

u/ml

3.21

189

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

625

2823

1.92

49.67

1.1

1.44

2.02

iu/ml

0.50

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

524

2226

2.04

49.58

3.0

2.7

—

(3052851) Hemolysis interference index of Serum or Plasma

1373

7718

1.55

49.42

3.3

3.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

891

4494

1.73

49.42

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

548

2372

2.01

49.24

1.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

290

958

2.62

49.18

1.8

2.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

964

4976

1.69

49.13

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

290

959

2.62

49.07

1.8

2.1

—

(3021901) Oxygen saturation in Capillary blood

904

4589

1.72

48.99

2.9

2.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1255

6933

1.58

48.74

1.9

2.3

0.04

0.03

g/l

0.13

1129

6357

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3074

20119

1.34

48.49

2.4

2.1

12.72

12.43

nmol/l

1.21

2697

18102

(3011412) CD3 cells [#/volume] in Blood

558

2447

1.98

48.34

2.2

2.5

1.30

1.19

e9/l

1.12

515

2180

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2146

13254

1.42

48.25

9.3

9.2

24.49

24.35

mmol/l

1.27

2063

12824

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

917

4695

1.70

48.17

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2504

15887

1.38

48.11

8.0

7.0

24.89

24.79

mmol/l

0.64

2486

15732

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

291

974

2.59

48.08

1.8

2.1

—

(1616796) Gas panel - Central venous blood

1078

5770

1.63

47.74

3.8

3.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

391

1503

2.26

47.71

1.5

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

614

2796

1.91

47.64

1.7

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

419

1663

2.19

47.31

2.3

2.8

0.22

0.24

e9/l

0.79

378

1420

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

777

3823

1.77

47.02

3.2

2.8

635.02

5901.98

u/ml

1.13

206

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1961

11984

1.43

46.73

4.9

4.3

24.16

24.14

mmol/l

0.07

1918

11722

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

961

5031

1.66

46.43

1.1

1.63

1.96

u/ml

0.48

476

2499

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1009

5354

1.64

46.26

1.6

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

805

4024

1.74

46.11

1.1

14.60

11.52

au/ml

0.47

259

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

383

1481

2.24

46.10

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2886

18867

1.34

45.76

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

421

1697

2.15

45.75

1.8

1.5

—

(3021788) Differential panel - Synovial fluid

906

4692

1.68

45.62

1.6

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1048

5652

1.62

45.01

3.1

3.6

—

(3010421) pH of Blood

1215

6815

1.55

44.15

4.2

3.7

7.42

0.09

1115

6219

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3623

24591

1.30

43.93

2.1

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

421

1726

2.12

43.83

2.3

2.7

567.09

530.67

e6/l

0.47

376

1426

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1151

6388

1.57

43.82

1.9

2.4

0.00

g/l

0.25

1027

5833

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

722

3551

1.77

43.78

1.1

2.61

2.90

u/ml

0.20

258

1842

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3969

27292

1.28

43.49

2.2

2.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1782

10876

1.43

42.71

4.9

3.8

49.38

48.30

1.08

1762

10755

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

281

981

2.48

42.62

2.0

1.9

85.72

137.58

umol/l

3.46

152

494

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3237

21731

1.31

42.52

4.3

3.7

1.23

mmol/l

1.09

2894

18878

(3037756) Immunofixation for Serum or Plasma

940

5010

1.63

42.36

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1215

6892

1.54

41.97

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

516

2315

1.93

41.91

1.6

1.4

278.48

279.51

mosm/kgh2o

0.42

406

1803

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

572

2656

1.87

41.87

1.8

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

572

2658

1.87

41.77

1.8

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

362

1429

2.20

41.50

1.4

5.25

5.95

u/l

1.46

298

1224

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

228

730

2.70

41.20

2.5

3.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1124

6295

1.56

41.12

1.9

2.4

0.00

g/l

-0.00

1023

5815

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1162

6561

1.54

40.99

1.3

1.4

488.84

548.70

mg/l

3.20

1089

6289

(3000330) Specific gravity of Urine by Test strip

2006

12598

1.39

40.83

4.0

3.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

457

1987

2.00

40.65

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

242

807

2.60

40.38

1.8

1.6

50858.63

19120.07

u/ml

0.36

105

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

452

1968

1.99

40.05

1.2

1.1

71.67

55.59

u/ml

—

(3010503) CD19 cells [#/volume] in Blood

372

1510

2.14

39.79

2.2

2.7

0.31

0.34

e9/l

0.06

363

1466

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

941

5097

1.61

39.73

1.5

1.4

13.95

20.96

u/ml

1.09

(3035637) Corticotropin [Mass/volume] in Plasma

650

3191

1.77

39.70

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1061

5920

1.56

39.47

4.2

3.8

4.97

5.00

kpa

0.45

1043

5774

(3013005) Retinol [Moles/volume] in Serum or Plasma

270

961

2.43

39.34

1.8

1.97

umol/l

0.01

248

905

(3012501) Base excess in Blood by calculation

1060

5919

1.56

39.30

4.2

3.8

2.46

2.50

mmol/l

0.17

733

4008

(3006270) Folate [Moles/volume] in Blood

454

1996

1.97

39.15

1.3

1.1

340.16

376.62

nmol/l

3.46

393

1671

(3027315) Oxygen [Partial pressure] in Blood

1064

5954

1.56

39.08

4.2

3.8

8.70

8.63

kpa

0.64

1046

5807

(3039000) Anion gap in Blood

1006

5569

1.57

38.74

6.7

6.5

11.31

11.17

mmol/l

0.68

923

5007

(3018572) Chloride [Moles/volume] in Blood

1006

5570

1.57

38.71

6.7

6.5

104.90

105.17

mmol/l

0.85

923

5008

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1450

8678

1.46

38.56

2.8

3.5

360.90

2260.59

u/ml

1.78

1223

7479

(3006653) Thiamine [Moles/volume] in Blood

308

1175

2.27

38.38

1.4

1.2

132.78

138.40

nmol/l

1.43

308

1175

(3019420) Tryptase [Mass/volume] in Serum or Plasma

333

1316

2.19

38.12

1.4

1.5

6.91

8.23

ug/l

0.95

308

1191

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

325

1285

2.19

37.17

1.1

87.66

82.67

u/l

0.38

301

1156

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

869

4703

1.61

36.84

1.3

285.95

263.82

u/ml

1.35

536

3009

(40767503) Oxygen content in Capillary blood by calculation

991

5549

1.55

36.31

2.8

2.4

16.62

16.52

0.30

550

2813

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

323

1287

2.17

36.26

1.1

24.55

23.79

u/l

0.07

296

1158

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

932

5148

1.58

36.25

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

367

1543

2.06

35.87

1.6

8.45

6.69

u/l

1.30

297

1238

(3045683) HLA typing for celiac disease panel - Blood or Tissue

348

1437

2.10

35.67

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

269

1000

2.33

35.64

30.3

27.9

112.67

116.92

ug/l

0.47

221

854

(3044290) Cell count panel - Cerebral spinal fluid

971

5440

1.55

35.50

1.3

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

764

4043

1.64

35.47

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

245

876

2.42

35.41

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2406

15917

1.32

34.88

9.8

9.0

93.83

93.94

0.40

2397

15859

(3020191) Ethanol [Moles/volume] in Serum or Plasma

446

2032

1.90

34.70

1.7

1.4

1.47

1.35

promille

0.87

353

1550

(1002224) Polysomnography panel

1821

11559

1.38

34.67

1.1

—

(3014271) Vancomycin [Susceptibility]

299

1179

2.20

34.47

2.8

2.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

202

667

2.62

34.47

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

228

799

2.47

34.42

1.7

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

634

3220

1.71

34.41

1.6

1.5

53.43

57.84

1.91

414

2047

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3136

21563

1.28

33.95

2.9

2.6

65.47

66.53

ml/min/173m2

0.75

1329

8310

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

759

4055

1.63

33.94

1.4

1.3

27.49

29.57

u/l

0.90

582

3351

(3026250) Tacrolimus [Mass/volume] in Blood

268

1018

2.28

33.81

35.5

34.3

7.30

7.28

ug/l

0.03

241

927

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

430

1956

1.91

33.63

1.2

—

(44813793) Dust mix specific IgE antibody measurement

404

1802

1.94

33.50

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

831

4571

1.58

32.94

1.1

4.25

4.85

u/ml

0.56

398

2326

(3020717) Zinc [Moles/volume] in Serum or Plasma

295

1180

2.16

32.86

1.5

23.22

26.02

umol/l

0.84

273

1122

(3006922) Hepatitis E virus Ab [Presence] in Serum

384

1696

1.96

32.78

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

317

1309

2.10

32.55

1.6

1.5

1.29

1.25

nmol/l

0.26

237

1031

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

427

1963

1.89

32.36

1.3

2.02

2.15

mmol/l

1.27

391

1826

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1006

5799

1.51

32.28

1.2

1.3

3.77

3.75

mmol/l

0.18

929

5474

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

255

969

2.28

32.17

1.8

1.7

27.62

29.72

umol/l

2.71

239

938

(3008401) Mugwort IgE Ab [Units/volume] in Serum

795

4353

1.59

32.14

1.1

0.83

1.11

u/ml

0.75

317

1841

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

443

2068

1.86

32.02

2.3

2.2

19.31

18.11

nmol/l

1.69

408

1959

(3010726) Horse dander IgE Ab [Units/volume] in Serum

776

4234

1.59

31.85

1.1

1.23

1.89

u/ml

1.82

363

2082

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

205

711

2.49

31.68

1.1

7.23

10.36

u/ml

1.21

416

(3023430) Cat dander IgE Ab [Units/volume] in Serum

647

3384

1.66

31.49

1.1

3.81

4.76

u/ml

0.65

252

1383

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

173

554

2.70

31.40

1.6

1.5

0.36

0.40

ug/l

0.67

115

359

(3016650) Hepatitis A virus Ab [Presence] in Serum

747

4071

1.59

30.82

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

752

4107

1.59

30.75

2.1

1.8

1.73

1.74

mmol/l

0.07

741

4001

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2366

15902

1.30

30.49

9.8

8.9

0.68

0.67

0.37

2349

15816

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

220

804

2.37

30.39

1.3

1.2

111.33

111.41

0.01

196

720

(40768441) Liver Pathology biopsy report

382

1737

1.91

29.98

1.4

1.3

—

(3020491) Glucose [Moles/volume] in Blood

399

1845

1.87

29.75

1.7

1.8

6.62

6.87

mmol/l

1.14

272

1322

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

157

492

2.76

29.72

1.3

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2361

15923

1.30

29.63

9.8

8.8

1.36

1.37

0.34

2341

15827

(3014133) Dog dander IgE Ab [Units/volume] in Serum

675

3631

1.61

29.42

1.1

3.42

4.18

u/ml

0.30

308

1697

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

942

5462

1.50

29.41

1.9

197.38

197.84

pmol/l

0.05

896

5184

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

583

3025

1.67

29.30

1.7

1.8

7008.89

3093.33

titre

0.31

132

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1081

6452

1.46

29.18

1.8

11.90

11.65

iu/l

0.01

378

2392

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1255

7710

1.42

28.97

1.8

1.7

42.07

41.45

nmol/l

0.36

1209

7524

(3011985) Renin [Units/volume] in Plasma

654

3511

1.62

28.75

1.6

1.5

66.66

65.37

mu/l

0.05

578

3133

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

363

1649

1.91

28.60

1.1

6.08

8.52

iu/ml

1.21

426

(3022806) Fractional oxyhemoglobin in Capillary blood

627

3339

1.63

28.48

2.0

1.8

90.29

89.69

1.79

620

3283

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

270

1106

2.11

28.39

1.5

1.6

2.26

10.39

nmol/l

0.94

220

931

(3040151) Glucose [Moles/volume] in Capillary blood

555

2867

1.68

28.38

6.6

6.7

7.43

7.25

mmol/l

0.25

431

2371

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1340

8361

1.40

28.28

3.2

0.35

0.36

u/ml

0.49

737

4792

(3051593) INR in Capillary blood by Coagulation assay

274

1132

2.10

28.18

7.5

10.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

827

4712

1.52

28.07

1.6

1.5

112.27

111.73

u/ml

0.04

199

1070

(3048879) Bone marrow aspiration report

188

664

2.45

28.03

1.8

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

392

1842

1.84

27.83

2.4

2.7

731.49

679.00

e6/l

0.70

383

1777

(3003129) Base excess in Capillary blood by calculation

169

570

2.56

27.75

1.8

1.7

0.95

0.61

mmol/l

0.47

159

541

(3009214) Lutropin [Units/volume] in Serum or Plasma

1207

7425

1.41

27.66

1.4

10.50

u/l

0.00

957

6029

(3029634) Reagin Ab [Titer] in Serum by VDRL

658

3573

1.60

27.62

2.0

2.1

13.92

6.91

titre

0.46

105

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

843

4847

1.51

27.43

3.5

3.1

—

(3024928) Oxygen saturation in Venous blood

885

5143

1.50

27.36

3.8

3.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

344

1559

1.91

27.32

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1142

6973

1.42

27.29

3.6

3.8

1.61

1.49

mg/l

4.62

1055

6411

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

884

5143

1.49

27.18

2.0

1.7

0.89

0.83

nmol/l

1.49

709

4328

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

185

659

2.43

27.10

1.7

1.6

9.51

8.84

ug/l

1.40

185

659

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

624

3364

1.61

27.00

1.8

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

226

882

2.22

26.86

1.3

1.2

0.30

0.31

g/l

1.01

187

696

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

344

1570

1.90

26.76

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1341

8447

1.38

26.75

2.3

2.2

4683.98

5245.37

u/l

0.28

413

3300

(3000093) Morphology [Interpretation] in Blood Narrative

459

2304

1.73

26.12

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

247

1012

2.11

26.01

2.3

2.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

402

1953

1.78

25.64

1.8

2.2

14.11

15.32

1.55

394

1902

(3033923) Metanephrine [Moles/time] in 24 hour Urine

148

488

2.62

25.48

1.1

0.79

0.78

umol/24h

0.01

242

(3002385) Erythrocyte distribution width [Ratio]

28948

241096

1.14

25.27

21.3

15.3

15.94

14.89

9.68

28616

236655

(1175426) CD3 cells/100 lymphocytes in Blood

405

1987

1.77

25.00

1.8

2.2

73.67

72.21

1.06

395

1909

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

609

3327

1.59

24.97

6.7

6.1

11.69

11.41

mg/l

0.87

558

3068

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

919

5481

1.46

24.96

1.4

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

521

2740

1.65

24.94

2.5

2.6

1.22

1.27

g/24h

0.13

257

1390

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

205

793

2.24

24.94

2.1

2.0

9.20

9.40

mg/l

0.20

170

625

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

919

5483

1.46

24.91

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

322

1474

1.89

24.87

1.3

1.2

86.37

90.54

u/l

0.30

276

1296

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1222

7680

1.38

24.73

1.8

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

158

549

2.49

24.46

1.2

1.3

17.25

16.88

umol/l

0.37

133

499

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

312

1432

1.89

23.93

1.3

1.2

23.89

25.25

u/l

0.17

265

1235

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

217

876

2.14

23.79

2.3

1.9

57.91

60.15

ug/l

0.15

211

854

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1072

6638

1.40

23.70

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

689

3932

1.52

23.30

1.3

32.42

31.47

u/l

0.09

591

3420

(3034274) Bile acid [Moles/volume] in Serum --fasting

518

2770

1.62

23.24

2.0

2.1

9.34

7.21

umol/l

0.80

367

2027

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

139

467

2.57

23.10

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

305

1419

1.86

22.46

1.7

1.8

1.44

2.53

u/field

3.70

219

1003

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

156

563

2.40

22.31

1.2

317.88

296.37

pmol/l

0.25

110

420

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

522

2826

1.60

22.29

1.9

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8863

69240

1.13

22.16

4.4

4.1

21.76

21.95

0.55

4129

33078

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

586

3271

1.55

21.95

1.4

1.3

307.78

381.32

pmol/l

0.94

500

2846

(3036489) Thrombin time

1501

9916

1.32

21.90

2.2

2.1

21.47

21.53

0.12

1281

8653

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

309

1460

1.83

21.69

1.0

1.1

6.52

5.24

nmol/l

0.19

293

(3042733) HLA Ab [Presence] in Serum

194

782

2.15

21.41

5.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

133

455

2.53

21.35

1.0

1.1

0.76

3.35

u/ml

0.75

399

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

466

2482

1.63

21.30

1.3

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

527

2893

1.58

21.25

2.9

2.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

385

1952

1.71

21.25

1.2

185.69

184.38

titre

0.01

336

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3508

25613

1.20

21.24

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

384

1947

1.71

21.19

1.2

250.00

144.22

titre

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

386

1961

1.70

21.15

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

385

1958

1.70

21.02

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

385

1959

1.70

20.98

1.2

—

(3017704) Immunofixation for Urine

278

1285

1.87

20.94

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

382

1944

1.70

20.81

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

432

2272

1.65

20.78

2.0

2.3

40.49

38.07

2.34

418

2238

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

382

1946

1.70

20.73

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

705

4144

1.48

20.71

1.4

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

381

1941

1.70

20.68

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

206

863

2.06

20.59

1.5

1.4

15.02

14.98

pmol/l

0.03

169

723

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5679

43256

1.15

20.42

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

285

4334

0.56

20.40

1.5

1.4

—

(21494434) Karyotype in Bone marrow

396

2047

1.68

20.37

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

1333

8760

1.32

20.21

4.4

4.0

1.36

1.37

mmol/l

0.07

1304

8612

(3043238) Trisomy 21 risk [Likelihood] in Fetus

296

4443

0.57

20.20

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

453

2432

1.61

20.08

1.1

—

(3005033) Fetal Nuchal fold Thickness US

286

4325

0.57

20.06

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

530

2959

1.55

19.89

1.1

1.0

0.43

0.41

u/ml

0.05

153

765

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2044

14219

1.25

19.83

2.8

3.5

40.95

54.57

u/ml

1.72

1957

13757

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1164

7525

1.34

19.75

2.5

2.6

187.56

186.78

0.11

1068

7147

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

721

4312

1.45

19.40

1.1

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

310

1520

1.77

19.31

1.3

464.44

371.95

titre

0.12

113

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

664

3917

1.47

19.19

1.3

1.2

3.66

3.73

u/ml

0.08

293

1711

(3016038) Potassium [Moles/volume] in Urine

313

1542

1.76

19.19

1.3

1.2

33.49

34.85

mmol/l

0.51

267

1324

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

115

388

2.56

19.05

1.2

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

303

1482

1.77

19.05

1.3

35.83

74.85

titre

2.03

130

(3012494) Peanut IgE Ab [Units/volume] in Serum

171

689

2.15

18.96

1.1

3.08

8.35

u/ml

0.47

392

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

335

1689

1.72

18.94

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

261

1223

1.85

18.90

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

360

1855

1.68

18.79

1.9

2.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

312

2.74

18.75

2.5

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

370

1924

1.66

18.66

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

929

5856

1.38

18.55

1.3

1.5

30.53

31.70

e6/l

0.03

716

4538

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

105

344

2.64

18.46

1.1

1.0

95.41

80.04

ug/l

2.54

287

(40762887) Creatinine [Moles/volume] in Blood

7.15

18.46

1.2

—

(40762814) Titanium [Mass/volume] in Blood

118

411

2.48

18.32

2.3

3.10

3.71

ug/l

1.06

136

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

928

5862

1.37

18.30

1.3

1.5

2858.51

2198.98

e6/l

0.11

766

4777

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1250

8261

1.32

18.23

2.5

2.4

93.93

92.40

1.58

1184

7934

(3010144) Erythrocytes [#/volume] in Synovial fluid

438

2392

1.59

18.14

1.5

1.4

148806.68

95535.35

e6/l

0.81

277

1677

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

162

652

2.15

18.04

1.8

1.7

148.21

143.67

au/ml

0.03

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

483

2702

1.55

18.02

2.5

—

(3028433) Virus identified in Specimen by Culture

189

808

2.02

17.96

1.3

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1174

7710

1.32

17.92

2.7

3.59

3.61

g/l

0.22

1102

7366

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

378

2002

1.63

17.77

1.1

267.19

278.71

mg/l

0.29

337

1763

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

390

2087

1.62

17.60

1.1

1.2

36.72

44.37

mg/l

2.28

329

1752

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

198

870

1.97

17.44

2.2

2.5

1.22

1.06

ug/l

0.45

182

828

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

460

2566

1.55

17.40

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

283

1395

1.76

17.38

2.3

2.0

100.23

99.69

0.10

259

1312

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

246

1163

1.83

17.36

4.1

3.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

171

715

2.07

17.28

1.3

40.88

40.19

g/l

0.25

403

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

228

1055

1.87

17.23

1.5

1.6

1727270.22

1764591.06

iu/ml

0.02

(3020891) Body temperature

1470

10006

1.28

17.14

5.6

4.6

—

(37021550) Renin [Units/volume] in Plasma --upright

132

499

2.29

17.14

1.3

64.92

77.76

mu/l

0.23

379

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

280

1382

1.75

17.12

2.2

2.5

1084.88

1078.24

u/ml

0.01

275

1368

(3008037) Lactate [Moles/volume] in Venous blood

857

5408

1.37

17.04

4.0

3.0

1.51

1.59

mmol/l

1.82

838

5294

(3016018) Differential panel - Cerebral spinal fluid

504

2887

1.51

16.90

1.3

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

812

5089

1.38

16.84

4.1

3.1

7.44

7.57

mmol/l

0.64

794

4997

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

846

9845

0.74

16.71

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

473

2680

1.53

16.70

3.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

157

648

2.09

16.44

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

986

6398

1.34

16.39

4.9

3.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

212

976

1.88

16.30

1.7

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1287

8676

1.29

16.22

1.7

292.59

310.12

mu/l

0.93

1167

7873

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

336

1779

1.63

15.88

1.6

1.5

22.55

24.75

u/ml

0.38

371

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

152

631

2.08

15.71

1.3

129.56

121.37

nmol/l

0.28

119

454

(21494814) CD8 cells/100 lymphocytes in Specimen

216

1013

1.84

15.70

1.7

2.1

—

(3024471) HLA-A [Type]

184

822

1.94

15.52

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

381

2093

1.58

15.48

1.9

2.0

2.17

2.30

u/field

0.14

201

868

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

5.18

15.48

1.1

0.22

0.20

g/l

0.55

(3024932) HLA-DR beta [Type]

180

800

1.94

15.41

1.1

—

(3044941) Cell count panel - Synovial fluid

652

4006

1.41

15.24

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

219

1044

1.81

15.13

1.1

441.67

625.68

ng/l

0.28

251

(3009015) Lactate [Moles/volume] in Synovial fluid

239

2.78

15.10

1.4

1.2

5.64

6.49

mmol/l

0.70

127

(3019230) Fractional oxyhemoglobin in Venous blood

688

4275

1.39

15.08

3.6

3.2

65.52

64.93

0.30

683

4254

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

827

5294

1.35

15.07

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

278

1424

1.69

14.96

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

243

1203

1.75

14.79

1.1

6.69

13.63

u/ml

0.70

109

(3004451) EKG impression Narrative

238

1173

1.75

14.71

1.4

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

205

2.91

14.66

1.0

3.00

4.91

u/ml

—

(3011436) Histone Ab [Units/volume] in Serum

130

523

2.15

14.60

1.1

—

35.83

u/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

643

3972

1.40

14.60

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

604

2.06

14.52

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

151

645

2.02

14.50

1.7

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1041

6935

1.30

14.40

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

655

4071

1.39

14.36

1.3

1.2

3.60

4.03

u/ml

0.25

233

1390

(3028707) Methadone [Presence] in Urine by Screen method

640

3963

1.40

14.34

2.5

2.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

185

852

1.88

14.29

5.8

6.4

24.43

25.35

mmol/l

2.50

167

780

(40757373) Influenza virus identified in Isolate

116

450

2.23

14.26

1.7

1.4

—

(3045142) Bone marrow Pathology biopsy report

471

2760

1.48

14.23

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

433

2496

1.50

14.18

1.8

2.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.98

14.07

1.0

1.2

0.26

0.68

umol/24h

0.81

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

229

1132

1.75

14.04

2.0

2.3

116.74

242.48

ug/l

0.45

221

1078

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

217

1057

1.77

14.00

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

298

1584

1.63

13.94

1.1

1.06

1.07

ratio

0.53

565

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

145

620

2.02

13.91

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

620

3840

1.40

13.89

1.1

121.75

117.89

2.29

562

3476

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

459

2691

1.48

13.85

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

211

1024

1.78

13.79

3.1

5.7

2086.04

2720.35

mg/l

0.16

135

754

(3002079) Sodium [Moles/time] in 24 hour Urine

231

1151

1.74

13.79

1.2

157.45

163.11

mmol/24h

0.46

231

1151

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

203

2.85

13.77

1.1

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

121

485

2.16

13.75

1.3

1.2

17.92

34.54

mg/l

0.31

361

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

196

932

1.82

13.71

2.5

2.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

1118

7574

1.28

13.62

4.9

4.3

3.86

3.88

mmol/l

0.64

1104

7517

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

760

4881

1.35

13.61

1.7

1.6

—

(1761868) Lipid panel - Serum or Plasma

11242

103285

0.91

13.59

3.0

2.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

419

2428

1.49

13.41

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

202

977

1.79

13.37

2.7

2.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

104

397

2.26

13.32

1.1

3.56

6.00

u/ml

0.30

282

(3020874) Milk IgE Ab [Units/volume] in Serum

295

1583

1.61

13.31

1.0

1.1

0.99

1.77

u/ml

1.08

121

495

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

141

607

2.01

13.30

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

141

607

2.01

13.30

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

141

607

2.01

13.30

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

141

607

2.01

13.30

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

469

2789

1.46

13.18

1.6

1.5

34.38

30.81

iu/ml

0.20

113

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

345

2.35

13.18

1.1

1.3

46.47

40.93

mg/l

0.45

299

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

324

2.40

13.17

1.0

0.02

0.43

u/ml

1.88

208

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

119

3.41

13.01

1.4

1.9

160.67

180.26

ug/g

0.37

102

(3011288) Drugs identified in Urine by Screen method

938

6258

1.30

12.89

2.6

2.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

460

5657

0.70

12.85

1.5

—

(40768446) Kidney Pathology biopsy report

203

996

1.76

12.82

1.8

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1145

7842

1.27

12.78

1.3

213.97

220.80

miu/ml

0.26

478

3587

(3012565) Volume of 24 hour Urine

253

1322

1.65

12.71

2.1

2.2

1881.27

1987.92

0.94

230

1166

(3027456) Digoxin [Moles/volume] in Serum or Plasma

698

4478

1.35

12.63

3.1

0.81

0.80

nmol/l

0.08

532

3476

(3025549) Creatine [Moles/time] in 24 hour Urine

200

2.76

12.47

1.5

1.4

—

13.10

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

289

1569

1.59

12.46

1.6

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

231

1189

1.68

12.31

1.8

1.9

138.35

146.14

0.83

213

1124

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

264

1407

1.62

12.29

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

322

2.33

12.01

1.4

93853.29

288775.25

nmol/l

0.80

276

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1403

9902

1.23

12.01

1.7

4.76

3.70

mg/l

1.47

1124

7180

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

434

5324

0.70

11.99

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

455

2742

1.44

11.97

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

339

2.29

11.94

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

435

5327

0.70

11.90

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1126

7777

1.26

11.74

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

845

5634

1.30

11.71

1.8

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

152

2343

0.56

11.67

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

433

5288

0.70

11.67

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

248

2.51

11.63

1.4

1.2

—

1.02

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

436

5309

0.71

11.56

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

153

712

1.86

11.55

1.9

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

440

2656

1.43

11.50

2.2

2.3

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

116

3.27

11.48

1.0

0.18

0.45

u/ml

0.63

107

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

346

1994

1.50

11.46

1.6

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

240

2.52

11.42

1.1

1.71

1.78

umol/24h

0.20

240

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

176

860

1.77

11.34

3.0

3.3

7.60

7.95

mg/l

0.32

133

683

(3000012) Reticulocyte production index

551

3468

1.38

11.31

2.3

2.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

216

2.60

11.30

1.0

0.09

0.17

u/ml

0.37

133

(3050129) First trimester maternal screen panel - Serum or Plasma

569

6604

0.74

11.18

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

619

3977

1.35

11.15

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

259

2.43

11.10

2.0

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2695

26538

0.87

11.04

1.8

1.7

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

219

2.56

11.00

1.0

1.1

0.22

4.52

u/ml

2.42

168

(3019977) pH of Arterial blood

251

1360

1.60

10.99

2.5

2.4

7.43

7.42

0.96

467

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

505

3150

1.39

10.97

1.7

1.9

21.90

25.12

ug/l

0.50

491

3094

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

287

2.35

10.96

1.9

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

185

927

1.72

10.94

1.2

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

392

2.14

10.91

2.2

3.1

15.23

14.83

ml/dl

0.75

362

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

758

1.80

10.85

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

258

1413

1.58

10.80

1.7

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

479

2971

1.40

10.77

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1330

9450

1.22

10.71

2.0

1.8

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

121

535

1.95

10.69

1.4

22.19

22.35

0.02

100

449

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

192

980

1.69

10.64

2.0

2.2

29.49

28.99

0.17

185

929

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

462

2855

1.40

10.62

1.1

94.93

96.33

0.56

424

2681

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

358

2.17

10.55

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

162

791

1.77

10.51

2.7

176.59

161.04

au/ml

0.18

108

(3010015) Selenium [Moles/volume] in Serum or Plasma

189

2.65

10.51

1.8

2.0

1.29

1.34

umol/l

0.44

167

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

918

6278

1.27

10.46

2.4

2.3

107.87

105.75

ug/min

0.05

537

3733

(3019174) dRVVT (LA screen)

215

2.53

10.42

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

194

999

1.68

10.41

2.1

2.3

11.22

10.68

0.20

183

934

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

254

1399

1.57

10.40

1.7

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

189

967

1.69

10.39

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6317

50236

1.10

10.35

3.2

2.9

0.69

0.77

ug/l

9.23

4231

32584

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

404

2451

1.43

10.33

4.2

5.0

88.97

118.12

u/ml

0.46

108

786

(3024869) Neuronal Ab [Presence] in Serum

105

448

2.02

10.27

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

329

2.20

10.24

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

542

3460

1.36

10.23

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

301

1730

1.50

10.17

1.4

12.61

12.47

u/l

0.14

286

1673

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

903

6194

1.26

10.05

1.4

152.14

133.86

pmol/l

0.39

882

6049

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

127

585

1.88

9.97

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

126

581

1.87

9.87

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

275

1564

1.52

9.79

1.0

1.1

3.66

2.62

u/ml

0.21

373

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

163

815

1.73

9.78

1.1

93.80

88.54

1.03

382

(3029075) Extractable nuclear Ab panel - Serum

151

739

1.77

9.76

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

284

1633

1.50

9.61

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

254

1426

1.54

9.60

1.1

1.07

1.08

u/l

0.12

118

655

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

443

2768

1.38

9.60

1.3

1.2

—

(3018133) Calcium [Moles/volume] in Urine

413

2.03

9.58

1.8

2.0

2.99

2.56

mmol/l

1.04

369

(40761539) Cells [Type] in Urine sediment by Light microscopy

133

631

1.82

9.54

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

194

2.54

9.51

1.9

2.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

298

1736

1.48

9.47

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1802

13319

1.17

9.44

1.4

1.3

27.59

30.57

iu/l

3.42

1541

11513

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

107

476

1.94

9.36

2.3

2.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

222

2.41

9.32

1.0

9.25

2.23

u/ml

0.34

122

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

254

2.31

9.31

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

506

3256

1.34

9.13

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

194

2.49

9.03

1.8

1.7

53.47

44.99

umol/l

0.78

194

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

367

4400

0.72

8.99

1.8

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

168

869

1.67

8.95

2.0

164.89

169.85

0.21

155

828

(3008536) Aspergillus sp Ab [Presence] in Serum

106

479

1.91

8.88

1.7

2.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

231

1295

1.54

8.84

1.9

2.5

197.46

206.80

u/l

1.13

231

1283

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

373

2.04

8.84

2.5

3.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

164

846

1.67

8.83

1.1

111.01

107.77

0.48

141

779

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

227

1270

1.54

8.77

1.2

1.3

57.57

60.81

0.13

154

(3009871) Measles virus Ab [Titer] in Serum

171

894

1.65

8.76

1.5

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

114

2.95

8.68

1.4

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

219

2.37

8.68

1.1

1.0

0.10

0.86

u/ml

1.04

121

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

162

840

1.67

8.57

1.1

91.30

89.09

0.41

390

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

231

2.32

8.57

1.0

1.1

0.18

2.58

u/ml

1.66

180

(3052592) Norovirus Ag [Presence] in Stool

105

479

1.89

8.57

1.2

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

139

2.73

8.53

1.6

1.3

19.07

17.46

pmol/l

0.22

123

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

216

2.36

8.48

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

299

2.14

8.44

2.1

2.6

0.64

0.57

u/field

0.22

299

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1773

17648

0.86

8.44

1.5

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

222

2.33

8.43

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

166

2.55

8.31

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

172

914

1.63

8.29

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

224

1270

1.52

8.18

1.2

1.3

4.03

4.64

umol/l

1.60

198

1172

(1001926) Buprenorphine [Presence] in Urine by Screen method

1027

7315

1.22

8.17

2.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

245

1416

1.50

8.17

1.4

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.68

8.14

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

206

2.35

7.99

1.1

1.0

0.22

0.61

u/ml

0.81

118

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

278

2.14

7.95

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

245

2.22

7.92

1.1

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

198

1101

1.55

7.91

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

144

741

1.68

7.89

2.0

2.3

1236.02

624.57

e6/l

0.30

400

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

136

2.67

7.80

5.3

4.8

—

(3025577) Chromium [Mass/volume] in Blood

258

1525

1.46

7.72

2.1

2.17

2.32

ug/l

0.36

208

1288

(40768793) Breast Pathology biopsy report

873

6154

1.23

7.72

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

265

1577

1.45

7.66

2.1

2.0

3.09

3.74

ug/l

1.00

235

1452

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

153

2.54

7.61

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.45

7.45

1.1

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

142

740

1.66

7.44

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

377

2408

1.35

7.25

3.0

2.9

48.07

54.45

mg/l

0.16

279

1711

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

211

1217

1.50

7.17

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

121

612

1.71

7.11

1.2

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

227

1332

1.47

7.10

2.1

2.2

26.30

35.24

umol/l

0.40

113

(3023410) Appearance of Cerebral spinal fluid

417

2721

1.33

6.97

1.4

1.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

103

501

1.78

6.95

2.2

2.5

7.31

7.56

mmol/l

0.26

294

(3033799) Differential panel - Peritoneal fluid

126

649

1.68

6.94

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

267

1625

1.42

6.89

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.88

6.87

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

242

1454

1.44

6.72

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

142

2.49

6.72

1.0

1.1

0.73

1.29

u/ml

0.32

103

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

137

2.52

6.70

1.0

0.16

1.69

u/ml

0.96

102

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1584

11916

1.15

6.69

1.9

1.8

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

122

2.62

6.69

1.2

1.1

62.26

107.57

u/l

0.42

102

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

169

2.35

6.65

2.4

4.1

1.88

2.18

mg/l

0.66

140

(3020650) Glucose [Presence] in Urine

132

699

1.63

6.56

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

203

2.21

6.55

1.2

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.42

6.54

1.3

1.8

224.65

266.20

nmol/l

0.15

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

435

1.81

6.53

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

145

787

1.59

6.52

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

570

3911

1.26

6.51

4.7

5.1

348.89

371.29

umol/l

3.26

502

3383

(3041672) Baker's yeast Ab [Presence] in Serum

109

2.69

6.49

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.29

6.43

1.1

1.2

—

(3051651) Icteric interference index of Serum or Plasma

253

1547

1.41

6.40

3.8

3.9

—

(3047189) Immunofixation for 24 hour Urine

191

1110

1.49

6.32

1.7

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

421

1.80

6.31

5.2

5.6

—

(3036603) Volume of Urine

279

1743

1.38

6.24

1.6

1925.01

1978.48

0.46

271

1697

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

191

2.21

6.21

5.8

6.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

127

2.51

6.20

1.7

1.6

184.74

197.44

ng/l

0.51

115

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

6.00

6.18

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

379

2487

1.32

6.15

1.5

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

181

2.24

6.14

1.3

1.2

12.33

22.84

0.78

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

289

1822

1.37

6.13

1.3

1.4

12.46

12.15

umol/l

0.32

273

1736

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

592

4111

1.25

6.12

1.1

25.42

3333.56

iu/ml

0.73

133

894

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

256

2.02

6.06

2.1

2.5

1.10

1.42

mmol/l

0.58

188

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

377

1.83

6.04

4.1

4.9

57.75

42.83

ug/min

0.95

298

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

275

1.98

5.98

2.0

1.6

1.33

1.73

mg/l

1.89

229

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

486

1.72

5.98

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

487

1.72

5.94

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

487

1.72

5.94

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

436

1.76

5.93

1.3

1.4

62.06

125.58

ng/l

1.75

273

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

107

552

1.67

5.93

1.1

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

411

1.79

5.92

1.8

2.3

1.19

1.20

mmol/l

0.27

395

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

152

856

1.53

5.87

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

301

1.92

5.87

1.7

1.5

122.64

108.77

ug/l

0.45

242

(40763791) Oxygen content in Venous blood by calculation

3.09

5.86

5.0

8.4

11.99

12.45

ml/dl

0.26

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

290

1.93

5.81

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

196

1166

1.45

5.81

1.1

100.27

97.48

0.52

163

923

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

137

2.39

5.77

1.1

15.52

41.22

u/ml

2.15

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

137

2.39

5.77

1.1

30.91

20.94

u/ml

0.66

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

314

2026

1.34

5.76

1.7

1.9

3.90

3.65

mg/l

0.43

298

1926

(3036180) Methadone [Presence] in Urine

188

1112

1.46

5.74

2.0

2.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

181

2.19

5.73

1.4

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

232

1429

1.40

5.69

1.0

0.44

1.19

u/ml

0.81

323

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

417

1.76

5.66

2.3

2.7

47.52

54.09

mg/l

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

334

2182

1.32

5.64

1.4

1.3

661.45

480.89

u/l

0.45

313

2084

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

148

837

1.53

5.63

1.7

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

325

2119

1.33

5.57

1.4

1.3

160.89

176.31

pmol/l

0.96

325

2119

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

315

1.86

5.46

1.3

1.2

—

(4034850) Laboratory test

1183

8853

1.16

5.45

10.9

9.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

314

3555

0.76

5.44

1.4

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

141

2.33

5.44

1.1

—

(40768806) Pleura Pathology biopsy report

374

2497

1.29

5.41

1.6

1.5

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

142

805

1.52

5.37

1.3

1.5

73.55

72.36

0.47

137

772

(3028308) Erythrocytes [#/volume] in Pleural fluid

391

2633

1.28

5.30

1.5

1.4

76792.83

50953.84

e6/l

0.60

248

1590

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

269

1719

1.35

5.30

1.3

13.52

14.32

u/l

0.17

245

1596

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

111

2.49

5.30

1.3

1.6

0.25

0.12

u/l

0.28

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

346

2295

1.30

5.27

1.2

1.3

8.77

8.51

mmol/l

0.52

336

2195

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

448

4832

0.80

5.26

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

408

1.73

5.23

1.1

3.26

7.41

pmol/l

0.51

(3003434) Protein [Mass/volume] in Pleural fluid

469

3235

1.25

5.22

1.5

1.4

33.69

33.46

g/l

0.15

426

2929

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

364

1.78

5.21

1.2

1.4

55.54

51.01

0.31

170

(3008116) Ketones [Moles/volume] in Urine by Test strip

480

1.67

5.20

1.8

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

425

2901

1.27

5.18

1.5

1.4

5030.44

2881.41

e6/l

0.48

323

2115

(3012989) Citrate [Moles/time] in 24 hour Urine

3.73

5.17

1.3

1.56

2.33

mmol/24h

1.69

(3003338) MCHC [Mass/volume]

27224

238508

0.95

5.16

23.8

16.3

331.98

332.60

g/l

24.75

27082

236680

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

376

2530

1.28

5.15

1.6

1.5

34.09

30.60

0.97

223

1579

(3023487) Leukocytes [#/volume] in Peritoneal fluid

134

758

1.53

5.14

2.1

1.7

675.87

5430.41

e6/l

2.13

500

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

342

2275

1.30

5.12

1.3

1.49

1.42

nmol/l

0.55

311

2054

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

360

1.77

5.11

1.2

1.1

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

1.34

0.87

mg/l

0.31

135

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

2.26

2.61

mg/l

0.17

139

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

1.07

2.09

mg/l

1.39

125

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

2.09

1.72

mg/l

0.21

142

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

2.30

2.36

mg/l

0.03

147

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

0.42

1.30

mg/l

2.14

128

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

3.62

2.34

mg/l

0.70

134

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

2.57

3.77

mg/l

0.93

126

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

196

2.07

5.11

1.7

1.6

2.34

1.77

mg/l

0.28

131

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

523

3662

1.23

5.10

1.3

7.00

7.24

mmol/l

1.18

470

3211

(3016750) Collection duration of Urine

237

1495

1.37

5.09

2.2

2.1

509.19

499.38

min

0.86

186

1068

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

202

2.05

5.09

1.8

1.6

2.08

1.74

mg/l

0.20

136

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

138

788

1.51

5.07

1.3

1.5

1149.84

674.91

mu/l

0.30

133

755

(3004775) Volume in Urine collected for unspecified duration

310

2039

1.31

5.04

2.4

2.2

715.77

665.05

1.35

218

1347

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

1114

1.43

5.03

1.6

1.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

292

1906

1.32

5.02

2.6

2.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

158

2.18

4.99

1.1

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.02

4.97

3.0

3.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

153

898

1.47

4.93

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

191

1169

1.41

4.93

1.5

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1940

15091

1.11

4.91

2.0

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

191

1170

1.41

4.90

1.5

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

121

677

1.54

4.90

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

117

651

1.55

4.86

1.5

1.3

42.19

39.16

0.35

437

(21491868) Cryoglobulin [Mass/volume] in Serum

149

873

1.47

4.85

1.2

0.98

0.34

g/l

0.53

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

251

1612

1.35

4.83

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

1180

8913

1.15

4.82

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

122

687

1.53

4.81

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

121

681

1.53

4.78

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

115

640

1.55

4.78

1.2

1.3

119.61

318.50

ug/l

1.22

351

(3034988) Calcium [Moles/volume] in Capillary blood

446

1.66

4.76

2.0

2.5

1.18

1.19

mmol/l

0.22

429

(3013293) Extractable nuclear Ab [Presence] in Serum

407

1.70

4.76

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

760

1.50

4.70

2.5

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

760

1.50

4.70

2.5

2.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

141

825

1.48

4.65

4.0

3.7

49.45

52.57

0.94

135

796

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

334

1.76

4.59

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

256

1664

1.33

4.57

5.7

6.6

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

199

1.99

4.57

1.2

18.42

14.89

nmol/l

0.81

(3021162) Amylase [Enzymatic activity/volume] in Specimen

393

1.69

4.55

2.5

2.9

2663.90

1295.75

u/l

0.37

353

(3003694) ABO and Rh group [Type] in Blood

9141

75689

1.05

4.53

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

507

1.60

4.49

1.5

1.2

12.75

14.47

g/l

1.05

399

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

177

2.05

4.48

1.0

1.1

6.71

10.74

u/l

1.26

177

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

151

903

1.44

4.47

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

389

1.69

4.45

1.5

1.4

0.20

0.25

nmol/l

0.63

271

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

325

1.75

4.43

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

156

2.10

4.35

1.0

0.04

2.16

u/ml

2.03

110

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

296

1.78

4.31

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

229

1479

1.34

4.30

2.6

2.8

39.17

38.81

0.12

143

800

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

216

1.92

4.29

2.9

2.7

22.71

22.38

mg/l

0.06

196

(3027696) Helicobacter pylori Ab [Titer] in Serum

4.67

4.28

1.1

1303.08

2713.33

titre

1.54

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

260

1719

1.31

4.16

1.0

299.80

339.50

ng/l

0.80

185

1218

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

371

0.37

4.11

1.4

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

234

1528

1.32

4.10

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

685

1.49

4.10

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.93

4.08

3.2

2.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

440

1.61

4.04

1.4

1.3

77.25

189.70

titre

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

203

1.91

4.02

1.2

1.1

16.00

17.80

iu/ml

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

105

2.30

4.00

1.0

1.1

286.52

495.24

u/l

0.71

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

145

2.08

3.95

1.1

1.4

4.02

3.62

u/ml

0.04

126

(40761995) Spermatozoa Progressive [#/volume] in Semen

497

0.47

3.95

3.6

3.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

115

670

1.48

3.94

2.0

1.6

12842.82

11241.13

e6/l

0.08

348

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

260

1734

1.30

3.93

1.0

47.23

41.38

ng/l

0.33

180

1207

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

496

0.47

3.93

7.2

6.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

175

1.97

3.90

1.1

—

(40765096) Chromosome analysis panel by Banding

123

728

1.46

3.90

1.2

—

(3015183) Erythrocyte sedimentation rate

214

1392

1.33

3.88

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

259

1731

1.29

3.86

1.0

798.99

740.58

ng/l

1.12

179

1178

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

174

1098

1.37

3.85

2.5

2.4

55.69

51.58

umol/l

0.87

146

942

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

327

1.69

3.83

1.8

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

205

1329

1.33

3.81

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

322

1.69

3.77

2.6

2.5

71.95

56.80

pmol/l

0.38

274

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

214

1.85

3.77

3.0

2.7

—

(3001556) Androgen free Index in Serum or Plasma

214

1.85

3.77

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

214

1.85

3.77

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

449

1.58

3.75

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

108

630

1.48

3.70

10.0

8.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

444

1.57

3.69

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

603

1.49

3.68

1.3

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

198

1286

1.33

3.65

1.2

1.1

3.25

4.37

iu/ml

0.93

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

229

1.81

3.65

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.18

3.63

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

372

1.62

3.63

1.2

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

216

1424

1.31

3.60

1.3

5.91

5.74

mmol/l

0.77

205

1335

(3044007) Cell count panel - Peritoneal fluid

104

607

1.48

3.57

2.0

1.7

—

(3024263) Appearance of Synovial fluid

209

1373

1.31

3.57

1.7

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

361

1.63

3.55

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

201

1315

1.32

3.54

1.5

4.73

3.98

0.26

295

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

276

1.72

3.54

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

213

1.82

3.52

1.3

11.37

13.70

pmol/l

0.25

183

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

412

2941

1.21

3.48

1.6

1.5

—

(3032641) Amino acids panel - Urine

4.31

3.48

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

214

1.81

3.47

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

120

725

1.43

3.46

1.4

1.3

3.19

3.57

mmol/l

0.79

104

672

(3036071) Salmonella sp Ab [Titer] in Serum

135

834

1.40

3.44

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.82

3.42

1.1

—

(3049233) Organic acids panel - Urine

3.62

3.42

1.3

1.2

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

7.55

3.40

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

352

1.62

3.40

1.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

178

1152

1.33

3.40

1.1

1493.51

1557.52

miu/ml

0.34

178

1152

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

118

1430

0.71

3.39

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.02

3.36

1.0

—

(3017569) Oxygen content in Arterial blood

179

1162

1.33

3.35

2.3

2.1

—

(3050794) Legionella sp Ab [Presence] in Serum

223

1.78

3.35

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

638

1.45

3.33

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

120

2.09

3.33

1.0

6.64

17.34

u/ml

1.72

100

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

533

1.49

3.31

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

127

784

1.40

3.27

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.81

3.21

1.2

1.5

163.60

149.03

nmol/l

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

230

1557

1.28

3.18

11.8

12.3

0.58

0.63

mmol/l

3.23

207

1433

(3042628) Porphyrins [Moles/volume] in Urine

8.62

3.18

1.2

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

196

1.81

3.14

1.2

104.17

97.13

ug/l

0.13

125

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

287

1.65

3.11

1.4

1.3

110.47

81.61

u/l

0.15

211

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

557

1.46

3.05

1.1

1.2

64.80

76.68

1.05

160

(3004446) Plasmodium sp identified in Blood by Light microscopy

256

1.69

3.04

2.3

2.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.29

3.04

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

218

1.74

3.01

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.65

3.00

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

304

1.62

2.98

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1228

9600

1.11

2.98

2.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

187

1.80

2.98

1.4

1.1

43.95

46.43

mg/l

0.16

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.21

2.93

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

124

779

1.37

2.92

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

247

1.68

2.89

1.2

1.1

—

(4212803) Bone marrow aspirate examination

189

1.78

2.89

1.2

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.24

2.88

1.2

2348.58

3460.30

ng/l

0.40

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

558

1.44

2.86

8.4

5.7

66.77

70.78

0.67

455

(3042517) Benzodiazepines panel - Urine

261

1.65

2.86

2.2

2.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.75

2.85

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.59

2.79

1.9

2.2

—

(3028300) Cannabinoids [Presence] in Urine

1234

9686

1.10

2.79

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

317

2267

1.21

2.72

1.4

1.3

6.23

6.33

mmol/l

0.18

291

2103

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

525

3919

1.16

2.72

1.5

1.4

0.34

0.37

nmol/l

0.35

412

2973

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

242

1684

1.24

2.71

18.0

17.6

1374.18

3347.93

nmol/l

1.06

229

1614

(3013466) aPTT in Blood by Coagulation assay

149

1.85

2.70

1.1

34.71

37.86

3.10

127

(3019768) Coxiella burnetii Ab [Presence] in Serum

149

1.85

2.70

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

162

1.81

2.68

1.0

0.23

0.27

u/ml

0.15

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

125

1.93

2.68

1.2

1.0

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

574

1.41

2.65

1.3

1.2

107.71

109.09

0.15

546

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

294

1.58

2.64

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

102

2.03

2.63

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

108

2.00

2.62

19.2

12.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.18

2.62

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

462

1.46

2.60

1.3

24.48

43.29

g/l

0.87

372

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1094

0.72

2.59

1.4

28.11

30.54

nmol/l

0.35

986

(3045716) Anion gap in Serum or Plasma

178

1203

1.28

2.58

3.0

2.3

9.90

9.78

mmol/l

0.16

172

1170

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

127

1.90

2.57

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

190

1.73

2.57

1.9

3.0

6.62

396.04

pmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

393

1.49

2.56

1.8

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

178

1.75

2.53

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

558

1.41

2.53

10.4

8.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

153

1.80

2.51

1.2

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

179

1.74

2.49

1.9

1.8

58.05

59.87

0.08

116

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

205

1.68

2.49

1.3

1.31

1.55

ml/s/173m2

0.21

132

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.08

2.47

1.0

1.1

155.70

225.87

pmol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.34

2.45

1.4

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.34

2.45

10.2

8.2

38.13

43.91

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.97

2.43

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.97

2.43

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.97

2.43

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.97

2.43

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.97

2.43

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.97

2.43

2.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.40

2.42

1.1

1.0

0.03

0.27

u/ml

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.46

2.39

1.0

388.44

339.65

umol/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

193

1334

1.25

2.35

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

568

4319

1.14

2.32

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

561

1.38

2.31

1.1

1.2

90.33

87.64

0.13

170

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

281

2891

0.84

2.30

1.4

3.96

3.86

ug/l

0.04

235

2463

(3003740) Influenza virus B Ag [Presence] in Specimen

568

4323

1.14

2.29

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

184

1.69

2.28

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

292

1.54

2.27

1.5

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

180

1240

1.25

2.27

2.1

86.13

108.49

ug/min

0.31

260

(3027008) Opiates [Presence] in Urine

1219

9671

1.09

2.26

2.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

328

1.50

2.23

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

226

1600

1.22

2.23

12.7

12.6

806.40

1453.96

nmol/l

0.53

215

1546

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

127

841

1.30

2.20

1.1

1.2

20.15

22.29

0.09

138

(3034426) Prothrombin time (PT)

134

894

1.29

2.20

1.2

—

(40758292) HTLV I+II Ab panel - Serum

443

1.42

2.19

1.3

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

126

835

1.30

2.18

1.5

1.4

59.60

62.02

0.32

102

701

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

123

1373

0.77

2.17

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.52

2.16

1.1

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

240

1722

1.20

2.09

2.1

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

143

970

1.27

2.08

2.3

3.0

28.02

28.78

umol/l

0.38

744

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

193

1359

1.23

2.04

4.8

5.9

347.96

3453.80

u/ml

0.70

268

(3051101) Glucose [Moles/volume] in Cord blood

501

0.64

2.03

4.4

5.7

—

(3041184) Isoniazid [Presence] in Urine

2.88

2.01

2.9

2.5

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

101

1.88

2.00

5.9

5.7

15.84

17.50

mmol/l

0.81

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.07

1.99

1.2

1.1

—

mmol/l

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.97

1.99

1.4

314.12

525.10

nmol/l

1.78

(3041918) Cholesterol [Moles/volume] in Pleural fluid

439

1.40

1.96

1.3

1.2

1.61

1.72

mmol/l

0.29

269

(3042010) Triglyceride [Moles/volume] in Pleural fluid

346

1.45

1.95

1.2

1.3

1.87

1.41

mmol/l

0.21

226

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

134

1.74

1.94

1.1

—

(3035880) pH of Pleural fluid

186

1314

1.22

1.92

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

598

1.33

1.87

1.1

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.18

1.84

1.0

1.1

379.43

267.53

nmol/l

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

150

1.67

1.82

1.1

1.2

1.40

1.13

u/field

0.58

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.20

1.78

4.9

5.7

0.26

0.25

mmol/l

0.06

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

189

1351

1.21

1.77

1.2

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.76

1.76

1.0

1.2

—

(40768795) Lymph node Pathology biopsy report

363

2739

1.14

1.76

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.02

1.75

1.7

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.25

1.73

3.7

2.1

1.21

2.41

mu/l

1.06

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.25

1.73

1.1

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

146

1.65

1.72

1.0

1.1

1.98

6.94

u/ml

2.19

104

(3002621) Streptococcal DNAse B [Units/volume] in Serum

242

1.50

1.71

1.0

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

292

1.45

1.69

1.5

1.3

29.94

22.95

0.67

228

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

127

1.70

1.69

5.0

3.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.20

1.66

1.3

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

169

1204

1.21

1.66

2.1

1.9

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.16

1.59

1.0

2.73

0.60

u/ml

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

104

1.74

1.56

12.5

8.4

—

(3017509) Phencyclidine [Presence] in Urine

276

1.44

1.56

1.9

1.5

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.76

1.54

1.0

0.10

0.37

u/ml

0.88

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

112

1.69

1.50

1.3

1.07

1.11

u/field

0.09

(3019832) Treponema pallidum Ab [Presence] in Serum

2697

22297

1.05

1.49

1.7

1.6

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.76

1.47

1.1

1.0

0.15

0.64

u/ml

1.01

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.90

1.46

1.3

1.7

164.13

116.56

ug/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.78

1.46

1.9

3.6

—

(3009677) Dengue virus Ab [Presence] in Serum

1.74

1.43

1.1

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

217

1.47

1.43

1.1

—

2.00

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

961

0.79

1.42

2.7

2.5

157.24

153.10

nmol/l

0.09

838

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

114

1.66

1.42

1.0

0.04

0.20

u/ml

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.92

1.40

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.92

1.40

2.6

2.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

3.08

1.39

1.2

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.08

1.39

1.0

1.2

18.78

34.41

nmol/24h

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.08

1.39

1.2

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

135

1.60

1.38

1.2

2762.74

1001.16

u/l

0.34

122

(3027944) Amphetamines [Presence] in Urine

1176

9529

1.07

1.38

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

479

4551

0.91

1.35

3.3

3.6

29.09

37.94

u/ml

1.23

451

4407

(3022689) Creatine [Moles/volume] in Urine

110

772

1.23

1.31

1.4

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

243

1.42

1.31

9.1

7.0

—

(3002619) Bacteria identified in Specimen by Culture

534

1.28

1.30

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

152

1.53

1.28

1.1

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

111

1.63

1.28

1.0

0.12

0.55

u/ml

—

(3016031) Almond IgE Ab [Units/volume] in Serum

159

1.52

1.28

1.0

0.32

0.89

u/ml

1.34

(3013945) Hepatitis B virus e Ab [Presence] in Serum

159

1.52

1.28

1.5

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

318

1.36

1.27

8.6

7.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.04

1.25

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.83

1.24

11.4

7.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.69

1.24

2.1

3.7

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.23

1.23

1.1

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.05

1.20

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

572

1.25

1.19

2.6

2.9

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

163

1.48

1.16

1.6

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

101

1.62

1.15

1.2

1.1

0.91

0.95

u/field

0.09

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.70

1.15

1.0

0.18

0.51

u/ml

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

192

1.44

1.15

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1803

14880

1.05

1.14

1.7

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

157

1.48

1.13

1.5

1.3

301.07

327.52

umol/24h

0.43

157

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

136

1.52

1.13

1.9

1.7

22.50

16.65

0.28

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

103

1.59

1.08

1.1

1.0

0.02

0.13

u/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.63

1.06

1.1

241.14

279.94

nmol/l

0.33

(40768800) Prostate Pathology biopsy report

589

5466

0.93

1.03

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.75

1.03

1.0

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

351

0.71

1.03

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

161

1.45

1.02

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

140

1.48

1.01

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.97

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

1241

1.15

0.97

3.7

3.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

244

1.34

0.96

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

258

1999

1.11

0.95

1.2

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

135

1.47

0.95

1.7

2.4

2.47

10.28

nmol/l

1.24

125

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

191

1860

0.89

0.93

1.3

1.54

1.55

g/l

0.32

191

1860

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.16

0.91

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

101

1.54

0.91

1.2

1.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.07

0.89

1.3

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

174

1.39

0.88

2.0

2.7

—

(3045788) Cell count panel - Pleural fluid

287

2257

1.10

0.83

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

304

1.28

0.83

1.5

1.4

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.92

0.83

1.5

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.92

0.83

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

428

1.23

0.82

6.7

7.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

169

1.38

0.82

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

274

1.29

0.82

1.5

1.4

68.38

73.40

0.46

235

(3001893) Eosinophils/100 leukocytes in Pleural fluid

713

1.17

0.81

1.5

1.4

2.47

2.80

0.16

614

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

155

1.39

0.81

1.4

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1137

9381

1.05

0.81

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

230

1.31

0.79

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.68

0.79

1.0

1.1

—

(3024316) Viscosity of Plasma

127

1.43

0.78

2.2

1.7

1.82

1.71

mpas

0.36

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.69

0.73

1.0

1.2

3.40

2.33

—

(3003577) Lead [Moles/volume] in Blood

203

1.32

0.73

1.0

1.5

0.14

0.24

umol/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

203

1.32

0.73

1.9

2.2

—

(3006598) pH of Arterial cord blood

147

0.65

0.70

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

183

1.32

0.68

1.1

1.5

10.05

12.49

0.42

125

(3013247) Albumin in CSF/Albumin in Serum or Plasma

590

1.17

0.68

1.1

6.27

7.14

mg/g

0.63

558

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

191

1.31

0.67

3.7

5.0

—

(3008607) Semen analysis panel

139

1.37

0.66

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

346

1.22

0.66

1.6

1.4

15.54

11.80

0.40

181

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.80

0.66

1.0

1.1

—

(3034614) HLA Ag [Interpretation]

1.58

0.65

1.3

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

174

0.69

0.64

1.2

1.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

650

1.15

0.64

1.3

23.56

21.75

0.25

599

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

309

1.23

0.63

1.1

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.52

0.61

1.0

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.61

0.0

1.9

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

1.66

0.60

1.2

1.5

193.66

169.02

nmol/l

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.66

0.60

1.0

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.66

0.60

1.0

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

296

1.22

0.59

1.3

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

339

2736

1.07

0.59

3.9

3.8

46.66

48.12

u/ml

0.06

331

2709

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

696

1.14

0.58

2.2

2.0

18.29

42.01

u/l

3.22

624

(3051387) C reactive protein [Mass/volume] in Capillary blood

718

5921

1.05

0.58

4.3

3.2

23.43

26.90

mg/l

1.83

408

3752

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.50

0.58

1.0

1.2

278.58

403.39

pmol/l

0.51

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

158

1.31

0.58

1.1

1.4

2.11

1.52

0.16

(3011544) Albumin [Mass/volume] in Pleural fluid

212

1.26

0.57

1.2

18.34

17.64

g/l

0.18

195

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.67

0.56

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

136

1.33

0.56

1.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.47

0.56

1.0

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.52

0.55

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

152

1.31

0.55

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

161

1.29

0.52

1.0

—

(3013762) Body weight Measured

0.64

0.49

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.51

0.48

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.49

0.48

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

125

1.31

0.48

1.0

0.23

0.40

u/ml

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

530

0.86

0.47

1.9

2.17

2.91

ug/l

0.57

327

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

196

1568

1.08

0.47

1.5

1.6

8.33

7.87

mmol/l

1.68

189

1508

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.44

0.46

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

362

1.17

0.46

5.9

9.4

0.32

0.34

umol/l

0.12

329

(40759632) Porphyrins [Mass/mass] in Stool

1.54

0.42

1.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.44

0.39

2.0

2.2

—

(3007463) Buprenorphine [Presence] in Urine

1.31

0.38

6.5

6.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

108

1.28

0.36

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

679

0.90

0.35

1.0

—

(3025130) Human papilloma virus identified in Specimen

442

3670

1.04

0.33

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.30

0.33

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.69

0.33

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

173

1.20

0.32

1.1

1.3

—

(36303858) Crystals [Presence] in Urine

1.37

0.31

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

327

1.13

0.31

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.34

0.31

4.6

3.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.34

0.31

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1074

9060

1.02

0.30

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

201

1828

0.95

0.30

1.6

1.7

—

(4281824) Cell count and differential, peritoneal fluid

325

2921

0.96

0.30

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

159

1.19

0.29

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

297

1.13

0.28

1.1

—

(46236302) HLA-C [Type] by High resolution typing

104

1.24

0.28

1.0

—

(40760409) HLA-A [Type] by High resolution

104

1.24

0.28

1.0

—

(40760410) HLA-B [Type] by High resolution

104

1.24

0.28

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.28

0.27

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

290

1.13

0.27

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

333

1.11

0.25

3.8

3.1

41.56

42.05

umol/l

0.05

288

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

432

1.10

0.25

2.0

1.8

—

(3013862) HLA-DP [Type]

106

1.22

0.25

1.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

211

1.14

0.24

1.1

1.5

44.57

39.33

0.27

133

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

220

1.14

0.23

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

626

1.07

0.23

2.3

2.8

123.90

110.44

ng/l

0.30

309

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

196

1.14

0.23

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

145

0.83

0.22

1.1

—

(3001729) Color of Synovial fluid

213

1.13

0.22

2.0

1.6

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.1

—

1.97

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

738

1.06

0.21

1.7

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

157

1.15

0.21

4.0

2.9

15.46

12.60

0.20

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.25

0.20

1.1

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.20

0.20

2.2

1.1

0.00

0.66

—

(3011325) HIV 1+2 Ab [Presence] in Serum

126

1.16

0.19

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

459

1.07

0.17

1.5

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.73

0.17

1.0

160.20

163.54

g/l

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

136

1.14

0.16

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.16

0.15

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

390

0.93

0.15

1.5

1.1

—

(40763590) HLA-DQ beta [Type]

104

1.16

0.15

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

774

1.05

0.15

2.1

1.9

—

(40758358) Immune stain study

129

1.14

0.14

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

137

0.88

0.12

1.0

—

(3000285) Sodium [Moles/volume] in Blood

323

1.07

0.12

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

117

0.88

0.10

1.0

—

(3022670) pH of Venous cord blood

1.10

0.09

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

144

1213

1.02

0.08

1.6

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

597

5201

0.99

0.08

1.6

—

(3014891) Appearance of Pleural fluid

321

1.05

0.07

1.4

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

334

0.96

0.07

2.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

297

1.05

0.06

1.7

2.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

262

0.95

0.05

1.6

1.2

20.79

20.95

mmol/l

0.05

212

(3013166) Neutrophils/100 leukocytes in Synovial fluid

820

1.02

0.05

1.7

1.4

52.67

54.57

0.19

696

(1617658) Protocol used for examination of sentinel lymph nodes

244

2128

0.99

0.05

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

118

0.95

0.01

1.2

—

(3022725) Serotonin [Moles/volume] in Serum

1.05

0.00

1.6

1.4

610.18

832.23

nmol/l

0.52

(46235168) Fasting glucose [Moles/volume] in Blood

323

0.99

0.00

2.2

2.0

6.64

7.48

mmol/l

0.75

129

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

109

1.03

0.00

2.3

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

240

1.01

0.00

1.1

16.44

20.33

u/l

1.00

143

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.94

-0.00

3.5

6.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.3

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.6

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.89

-0.00

1.1

1.29

1.28

u/field

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_REFLUX and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_REFLUX	1.086 [1.0, 1.18]	0.045
Birth year	0.994 [0.99, 1.0]	0.196

During the follow-up period (1.1.1998 — 31.12.2019), 15214 out of 108719 females with K11_REFLUX died.

Males

Parameter	HR [95% CI]	p-value
K11_REFLUX	1.289 [1.19, 1.4]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 18165 out of 94271 males with K11_REFLUX died.

Mortality risk

Mortality risk for people of age

years, who have K11_REFLUX.

N-year risk	Females	Males
1	0.114%	0.243%
5	0.634%	1.493%
10	1.6%	3.681%
15	2.999%	6.704%
20	5.296%	11.685%

Relationships between endpoints

↥

Index endpoint: K11_REFLUX – Gastro-oesophageal reflux disease

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Gastro-oesophageal reflux disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints